-DOCSTART- -X- N

hippotherapy NN Physical
simulator NN Physical
hippotherapy NN Physical
( ( Physical
when WRB Physical
applied VBN Physical
by IN Physical
a DT Physical
simulator NN Physical
) ) Physical
intervention NN Physical
( ( Physical
simulator NN Physical
ON NNP Physical
) ) Physical
or CC None
control NN Control
( ( Control
simulator VB Control
OFF NNP Control
) ) Control
Hippotherapy NNP Physical
-DOCSTART- -X- N

CGM NNP Other
control NN Control
standard JJ Control
home NN Control
blood NN Control
glucose JJ Control
monitoring NN Control
CGM NNP Other
-DOCSTART- -X- N

Cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
group-based JJ Educational
cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
( ( Educational
CBSM NNP Educational
) ) Educational
intervention NN Educational
wait-list NN Control
control NN Control
condition NN Control
CBSM NNP Educational
intervention NN Educational
battery NN None
of IN None
administered VBN None
by IN None
a DT None
research NN None
assistant NN None
at IN None
baseline NN None
, , None
immediately RB None
following VBG None
the DT None
10-week JJ Educational
CBSM NNP Educational
intervention NN Educational
period NN None
, , None
and CC None
at IN None
a DT None
6-month JJ None
follow-up NN None
. . None
-DOCSTART- -X- N

nutritional JJ Educational
education NN Educational
program NN Educational
nutrition JJ Educational
education NN Educational
program NN Educational
educational JJ Educational
interventions NNS Educational
: : Educational
usual JJ Educational
intervention NN Educational
of IN Educational
5 CD Educational
minutes NNS Educational
of IN Educational
counseling NN Educational
, , Educational
or CC Educational
a DT Educational
special JJ Educational
intervention NN Educational
of IN Educational
2 CD Educational
hours NNS Educational
of IN Educational
behaviorally RB Educational
based VBN Educational
education NN Educational
on IN Educational
dietary JJ Educational
changes NNS Educational
to TO Educational
lower VB Educational
serum NN Educational
cholesterol NN Educational
. . Educational
behaviorally RB Educational
based VBN Educational
nutrition JJ Educational
education NN Educational
program NN Educational
Nutrition NNP Educational
education NN Educational
-DOCSTART- -X- N

Sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
N-acetylcysteine NNP Pharmocological
, , None
and CC None
saline NN Control
sodium NN Pharmocological
bicarbonate NN Pharmocological
combination NN None
of IN None
N-acetylcysteine NNP Surgical
( ( Surgical
NAC NNP Surgical
) ) Surgical
plus CC None
sodium JJ Pharmocological
chloride NN Pharmocological
and CC None
sodium NN Pharmocological
chloride NN Pharmocological
alone RB None
infusion NN None
of IN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
plus CC None
oral JJ None
NAC NNP Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
combination NN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
chloride JJ Pharmocological
infusion NN Pharmocological
Combination NNP None
therapy NN None
of IN None
NAC NNP Pharmocological
plus CC Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
. . None
-DOCSTART- -X- N

brisk JJ Physical
walking VBG Physical
in IN Physical
two CD Physical
different JJ Physical
environments NNS Physical
: : Physical
30 CD Physical
minute NN Physical
brisk NN Physical
walk VBP Physical
-DOCSTART- -X- N

dihydropyridine JJ Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
nitrendipine NN Pharmocological
placebo VB Control
nitrendipine VB Pharmocological
Nitrendipine NNP Pharmocological
placebo VB Control
nitrendipine JJ Pharmocological
nitrendipine NN Pharmocological
nitrendipine JJ Pharmocological
-DOCSTART- -X- N

by IN None
a DT None
direct JJ None
PCR NNP None
method NN None
in IN None
fecal JJ None
samples NNS None
from IN None
mothers NNS None
breast-milk JJ Physical
samples NNS Physical
1 CD None
month NN None
post-partum NN None
. . None
-DOCSTART- -X- N

Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospheres NNP Pharmocological
vs. FW None
Creon NNP Pharmocological
8,000 CD Pharmocological
microspheres NNS Pharmocological
-- : None
an DT None
Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospherestrade NNP Pharmocological
mark NN Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
) ) Pharmocological
microspheres NNS Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
8,000 CD Pharmocological
) ) Pharmocological
. . Pharmocological
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
8,000 CD Pharmocological
ms NN Pharmocological
followed VBN None
by IN None
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
, , None
or CC None
vice NN None
versa NN None
. . None
( ( None
Creon JJ Pharmocological
Creon NNP Pharmocological
-DOCSTART- -X- N

rofecoxib NN None
indomethacin NN None
indomethacin NN Pharmocological
COX-2 NNP Pharmocological
selective JJ Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
-- : None
has VBZ None
COX-2 NNP Pharmocological
selective NN Pharmocological
indomethacin NN Pharmocological
rofecoxib NN Pharmocological
rofecoxib NN Pharmocological
indomethacin NN Pharmocological
-DOCSTART- -X- N

vincristine NN Pharmocological
, , Pharmocological
corticosteroids NNS Pharmocological
, , Pharmocological
and CC Pharmocological
anthracyclines NNS Pharmocological
intensified VBN Pharmocological
with IN Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
asparaginase NN Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
. . None
cytarabine JJ Pharmocological
mitoxantrone NN Pharmocological
4-drug JJ Pharmocological
induction NN Pharmocological
( ( Pharmocological
the DT Pharmocological
L-20 NNP Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
. . Pharmocological
consolidation NN Pharmocological
, , Pharmocological
maintenance NN Pharmocological
therapy NN Pharmocological
, , Pharmocological
and CC Pharmocological
central JJ Pharmocological
nervous JJ Pharmocological
system NN Pharmocological
prophylaxis NN Pharmocological
. . None
-DOCSTART- -X- N

peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a JJ Pharmocological
peginterferon VB Pharmocological
alfa-2a JJ Pharmocological
peginterferon NN Pharmocological
alfa-2a JJ Pharmocological
plus CC Pharmocological
lamivudine JJ Pharmocological
. . Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
pegylated JJ Pharmocological
interferon NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Albendazole JJ Pharmocological
albendazole NN Pharmocological
dexamethasone NN Pharmocological
albendazole JJ Pharmocological
corticosteroids NNS Pharmocological
-DOCSTART- -X- N

Simvastatin NNP Pharmocological
simvastatin NN Pharmocological
simvastatin NN None
( ( None
80 CD None
mg/day NN None
) ) None
or CC None
placebo NN None
. . None
RESULTS NNP None
Simvastatin NNP None
-DOCSTART- -X- N

action NN Physical
observation NN Physical
treatment NN Physical
( ( Physical
AOT NNP Physical
) ) Physical
or CC None
control NN Control
group NN None
. . None
observe VB Educational
video JJ Educational
clips NNS Educational
showing VBG Educational
daily JJ Educational
actions NNS Educational
and CC Educational
to TO Educational
imitate VB Educational
them PRP Educational
afterward RB Educational
. . Physical
observe VB Educational
video JJ Educational
clips NNS Educational
with IN Educational
no DT Educational
motor NN Educational
content NN Educational
and CC Educational
to TO Educational
execute VB Educational
the DT Educational
same JJ Educational
actions NNS Educational
as IN Educational
patients NNS Educational
in IN Educational
the DT Educational
case NN Educational
group NN Educational
-DOCSTART- -X- N

small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
needle-knife JJ Physical
group NN Physical
physiotherapy NN Physical
group NN Physical
needle-knife JJ Physical
small JJ Physical
needle-knife JJ Physical
releasing NN Physical
therapy NN Physical
, , Physical
blocking VBG Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
physiotherapy NN Physical
ultra-short JJ Physical
wave NN Physical
, , Physical
modulated VBD Physical
medium NN Physical
frequency NN Physical
current JJ Physical
, , Physical
massage NN Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
needle-knife JJ Physical
needle-knife JJ Physical
needle-knife JJ Physical
physiotherapy NN Physical
Small NNP Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
-DOCSTART- -X- N

Cyclosporin NNP Pharmocological
versus NN None
cyclophosphamide NN Pharmocological
cyclosporin NN Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
cyclophosphamide NN Pharmocological
cyclophosphamide VB Pharmocological
CsA NNP Pharmocological
cyclophosphamide-treated JJ Pharmocological
cyclophosphamide NN Pharmocological
CsA NNP Pharmocological
cyclophosphamide NN Pharmocological
cyclophosphamide JJ Pharmocological
-DOCSTART- -X- N

questionnaire NN None
-DOCSTART- -X- N

bladder NN Physical
flap NN Physical
bladder NN Physical
flap NN Physical
abdominal JJ Surgical
surgeries NNS Surgical
cesarean JJ Surgical
deliveries NNS Surgical
omission NN Physical
of IN Physical
the DT Physical
bladder NN Physical
flap NN Physical
-DOCSTART- -X- N

Margarines NNS None
fortified VBN None
with IN None
?-linolenic JJ None
acid NN None
, , None
eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
, , None
or CC None
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
of IN None
?-linolenic JJ None
acid NN None
( ( None
ALA NNP None
) ) None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
incorporated VBN None
which WDT None
margarines NNS None
fortified VBD None
with IN None
either DT None
10 CD None
weight NN None
percent NN None
ALA NNP None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
ethyl VBP None
esters NNS None
replaced VBD None
-DOCSTART- -X- N

placebo-controlled JJ Control
Sirolimus NNP Pharmocological
placebo NN Control
or CC None
usual-dose JJ None
or CC None
high-dose JJ None
sirolimus NN Pharmocological
. . None
-DOCSTART- -X- N

thiopentone/guaifenesin NN Pharmocological
, , None
ketamine/guaifenesin NN Pharmocological
and CC None
ketamine/midazolam NN Pharmocological
acepromazine VBP Pharmocological
xylazine JJ Pharmocological
thiopentone NN Pharmocological
guaifenesin NN Pharmocological
guaifenesin NN Pharmocological
and CC None
2.2 CD None
mg/kg NN None
ketamine NN Pharmocological
midazolam NN Pharmocological
ketamine NN Pharmocological
isoflurane NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
patients NNS None
were VBD None
treated VBN None
with IN None
placebo NN Control
followed VBN None
by IN None
hydrochlorothiazide NN Pharmocological
. . None
hydrochlorothiazide JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
placebo NN Control
hydrochlorothiazide NN Pharmocological
. . Pharmocological
hydrochlorothiazide NN Pharmocological
-DOCSTART- -X- N

Gefitinib NNP Pharmocological
plus CC None
best JJS Other
supportive JJ Other
care NN Other
placebo-controlled JJ Control
gefitinib NN Pharmocological
gefitinib NN Pharmocological
( ( Pharmocological
250 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
, , None
plus CC Other
best JJS Other
supportive JJ Other
care NN Other
. . None
gefitinib NN Pharmocological
-DOCSTART- -X- N

individualized JJ Educational
patient JJ Educational
education NN Educational
intervention NN Educational
individualized JJ Educational
telephone NN Educational
patient JJ Educational
education NN Educational
intervention NN Educational
education NN Educational
pre-discharge NN Educational
educational JJ Educational
intervention NN Educational
-DOCSTART- -X- N

bare-metal JJ Physical
stent JJ Physical
implantation NN Physical
with IN Physical
sirolimus-eluting JJ Physical
stent NN Physical
implantation NN Physical
sirolimus-eluting JJ Surgical
Cypher NNP Surgical
stents NNS Surgical
( ( Surgical
SESs NNP Surgical
) ) Surgical
SESs NNP None
BMSs NNP None
-DOCSTART- -X- N

( ( Pharmocological
FU NNP Pharmocological
) ) Pharmocological
+ VBP None
hydroxyurea NN Pharmocological
( ( Pharmocological
HU NNP Pharmocological
) ) Pharmocological
vs. FW None
methyl-CCNU NN Pharmocological
, , None
oncovin NN Pharmocological
, , None
fluorouracil NN Pharmocological
, , None
and CC None
streptozotocin NN Pharmocological
( ( Pharmocological
MOF-Strep NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

Arthroscopic NNP Surgical
rotator NN Surgical
cuff NN Surgical
repair NN Surgical
with IN Surgical
and CC None
without IN Physical
acromioplasty NN Physical
arthroscopic VBN Surgical
cuff JJ Surgical
repair NN Surgical
with IN Surgical
or CC None
without IN Physical
acromioplasty JJ Physical
-DOCSTART- -X- N

intervention NN Other
control NN Control
-DOCSTART- -X- N

intercostal JJ Pharmocological
nerve NN Pharmocological
blocks NNS Pharmocological
morphine NN Pharmocological
Intercostal NNP Pharmocological
nerve NN Pharmocological
blocks NNS Pharmocological
( ( Pharmocological
INB NNP Pharmocological
) ) Pharmocological
subarachnoid JJ Pharmocological
morphine NN Pharmocological
( ( Pharmocological
SM NNP Pharmocological
) ) Pharmocological
SM NNP Pharmocological
INB NNP Pharmocological
bupivacaine NN Pharmocological
SM NNP Pharmocological
INB NNP Pharmocological
saline NN Control
INB- NNP None
INB+ NNP Pharmocological
INB+ NNP Pharmocological
INB- NNP Pharmocological
INB- NNP Pharmocological
INB+ NNP Pharmocological
INB NNP Pharmocological
SM NNP Pharmocological
INB NNP Pharmocological
SM NNP Pharmocological
-DOCSTART- -X- N

Genotyping VBG Other
of IN Other
CYP21 NNP Other
genotyping VBG Other
9 CD Other
CYP21 NNP Other
Blood-impregnated JJ Other
filter NN Other
papers NNS Other
17-hydroxyprogesterone CD Other
CYP21 NNP Other
PCR NNP Other
CYP21 NNP Other
-DOCSTART- -X- N

oxygen NN Other
and CC None
hypoxic NN Other
gas NN Other
arterial JJ None
oxygen NN None
saturations NNS None
( ( None
SaO2 NNP None
) ) None
100 CD Other
percent NN Other
oxygen NN Other
room NN Other
air NN Other
-DOCSTART- -X- N

polyfrequency NN Physical
oscillation NN Physical
method NN Physical
bodyplethysmograph NN Physical
transcutaneous JJ Pharmocological
oxygen NN Pharmocological
pressure NN Pharmocological
bodyplethysmography NN Physical
polyfrequent JJ Physical
oscillation NN Physical
method NN Physical
-DOCSTART- -X- N

imitation NN Psychological
contingently RB Psychological
responsive JJ Psychological
imitation NN Psychological
contingency NN Educational
imitative JJ Psychological
-DOCSTART- -X- N

Moderate NNP Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
, , None
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
, , None
and CC None
thiazide RB Pharmocological
diuretic JJ Pharmocological
in IN None
Dietary NNP Physical
sodium JJ Physical
restriction NN Physical
sodium JJ Physical
Angiotensin NNP Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
The DT None
combination NN None
of IN None
dietary JJ Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
with IN None
blockade NN None
of IN None
the DT None
renin NN None
system NN None
by IN None
an DT None
ACE NNP Pharmocological
inhibitor NN Pharmocological
thiazide JJ Pharmocological
diuretic NN Pharmocological
-DOCSTART- -X- N

transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
group NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Eye NNP Physical
point NN Physical
group NN Physical
control NN Control
group NN Control
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
pressurization NN None
and CC None
connected VBN None
line NN None
were VBD None
the DT None
same JJ None
with IN None
group NN None
A NNP None
, , None
but CC None
without IN None
electrical JJ Control
stimulation NN Control
. . None
-DOCSTART- -X- N

rectal JJ None
midazolam NN Pharmocological
and CC None
diazepam NN Pharmocological
midazolam NN Pharmocological
diazepam NN Pharmocological
placebo NN Control
rectal JJ Pharmocological
medications NNS Pharmocological
midazolam NN Pharmocological
placebo NN Control
. . Control
midazolam NNS Pharmocological
midazolam NNS Pharmocological
diazepam NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

norfloxacin NN Pharmocological
norfloxacin NN Pharmocological
and CC None
trimethoprim/sulfamethoxazole NN Pharmocological
Norfloxacin NNP Pharmocological
, , None
trimethoprim/sulfamethoxazole NN Pharmocological
, , None
cytokines NNS Pharmocological
, , None
nitric JJ Pharmocological
oxide NN Pharmocological
Trimethoprim/sulfamethoxazole NNP Pharmocological
Norfloxacin NNP Pharmocological
trimethoprim/sulfamethoxazole JJ Pharmocological
-DOCSTART- -X- N

magnesium NN Pharmocological
levobupivacaine VB Pharmocological
magnesium NN Pharmocological
0.25 CD None
% NN None
levobupivacaine NN Pharmocological
and CC None
1 CD None
ml NN None
of IN None
15 CD None
% NN None
magnesium NN Pharmocological
sulphate NN Pharmocological
Group NNP None
L NNP None
was VBD None
administered VBN None
20 CD None
ml NN None
of IN None
0.25 CD Pharmocological
% NN Pharmocological
levobupivacaine NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

standard JJ Pharmocological
danazol NN Pharmocological
and CC None
modified VBD Pharmocological
triptorelin NN Pharmocological
regimens NNS Pharmocological
danazol NN Pharmocological
and CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
or CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin NN Pharmocological
. . Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin JJ Pharmocological
triptorelin NN Pharmocological
danazol NN Pharmocological
. . Pharmocological
triptorelin JJ Pharmocological
-DOCSTART- -X- N

posterior JJ Physical
tibial JJ Physical
nerve NN Physical
stimulation NN Physical
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
placebo NN None
Posterior NNP None
tibial JJ None
nerve NN None
stimulation NN None
-DOCSTART- -X- N

right JJ Physical
ventricular JJ Physical
myocardial JJ Physical
isovolumic JJ Physical
relaxation NN Physical
time NN Physical
. . None
RV NNP Physical
IVRT NNP Physical
( ( Physical
IVRT NNP Physical
' POS Physical
) ) Physical
invasively RB Surgical
measured VBN Surgical
PAP NNP Surgical
. . Surgical
Transthoracic NNP Physical
echocardiography NN Physical
with IN Physical
myocardial JJ Physical
velocity NN Physical
imaging NN Physical
and CC Physical
right JJ Surgical
heart NN Surgical
catheterization NN Surgical
-DOCSTART- -X- N

low-tilt JJ Physical
biphasic JJ Physical
waveform NN Physical
low-tilt JJ Pharmocological
waveform NN Pharmocological
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Physical
waveform NN Physical
conventional JJ Physical
waveform NN Physical
. . None
low-tilt JJ Physical
waveform NN Physical
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Pharmocological
biphasic JJ Pharmocological
waveform NN Pharmocological
-DOCSTART- -X- N

radiation NN Surgical
therapy NN Surgical
split VB Surgical
course NN Surgical
radiation NN Surgical
therapy NN Surgical
combined VBN None
with IN None
mitomycin JJ Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
fluorouracil NN Pharmocological
radiotherapy NN Surgical
, , None
50 CD None
Gy NNP None
in IN None
20 CD None
fractions NNS None
in IN None
28 CD None
days NNS None
split JJ Surgical
course NN Surgical
radiotherapy NN Surgical
and CC None
concurrent NN Pharmocological
chemotherapy NN Pharmocological
, , None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
followed VBN None
by IN None
a DT None
4 CD None
week NN None
rest NN None
and CC None
a DT None
further JJ None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
starting VBG None
on IN None
day NN None
43 CD None
; : None
Mitomycin NNP Pharmocological
C NNP Pharmocological
was VBD None
given VBN None
on IN None
day NN None
1 CD None
and CC None
day NN None
43 CD None
and CC None
5FU CD Pharmocological
continuous JJ None
infusions NNS None
on IN None
days NNS None
1 CD None
-- : None
4 CD None
and CC None
days NNS None
43 CD None
-- : None
46 CD None
. . None
radiotherapy NN Surgical
concurrent JJ Pharmocological
chemotherapy NN Pharmocological
with IN None
Mitomycin NNP Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
Fluorouracil NNP Pharmocological
-DOCSTART- -X- N

tactile JJ Physical
massage NN Physical
non-pharmacological JJ Other
therapies NNS Other
tactile JJ Physical
massage NN Physical
( ( Physical
TM NNP Physical
) ) Physical
. . Other
. . Control
TM NNP Physical
TM NNP Physical
TM NNP Physical
RTM NNP Control
-DOCSTART- -X- N

valproate NN Pharmocological
prophylactic JJ None
drug NN None
. . None
valproate NN Pharmocological
migraine JJ Pharmocological
prophylactic JJ Pharmocological
drug NN Pharmocological
. . Pharmocological
Valproate VB Pharmocological
or CC None
placebo NN Control
GTN NNP Pharmocological
placebo NN Control
valproate NN Pharmocological
placebo NN Control
valproate NN Pharmocological
valproate NN Pharmocological
valproate NN Pharmocological
placebo NN Control
valproate NN Pharmocological
placebo VB Control
valproate NN Pharmocological
valproate NN Pharmocological
model NN Pharmocological
. . Pharmocological
valproate NN Pharmocological
placebo VB Control
The DT None
GTN NNP Pharmocological
model NN Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
[ NN Pharmocological
17 CD Pharmocological
] NN Pharmocological
amantadine NN Pharmocological
or CC None
placebo NN Control
amantadine NN Pharmocological
placebo NN Control
amantadine NN Pharmocological
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
risperidone NN Pharmocological
plus CC Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
to TO Pharmocological
risperidone VB Pharmocological
risperidone JJ Pharmocological
plus CC Pharmocological
amantadine JJ Pharmocological
, , None
and CC None
the DT None
other JJ None
group NN None
received VBD None
risperidone JJ Pharmocological
plus CC Pharmocological
placebo NN Control
. . None
amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
-DOCSTART- -X- N

monoiodoacetate NN Pharmocological
. . None
monoiodoacetate NN Pharmocological
( ( Pharmocological
MIA NNP Pharmocological
) ) Pharmocological
MIA NNP Pharmocological
phenylbutazone NN Pharmocological
, , None
butorphanol NN Pharmocological
, , None
and CC None
abaxial JJ Pharmocological
sesamoidean NN Pharmocological
nerve NN Physical
blocks NNS Physical
non-exercised JJ None
exercised JJ None
Exercise NNP Physical
-DOCSTART- -X- N

self-expanding JJ Surgical
nitinol JJ Surgical
stent NN Surgical
implantation NN Surgical
balloon NN Surgical
angioplasty NN Surgical
stent JJ Surgical
placement NN Surgical
conventional JJ Surgical
balloon NN Surgical
angioplasty NN Surgical
( ( Surgical
percutaneous JJ Surgical
transluminal NN Surgical
angioplasty NN Surgical
[ NNP Surgical
PTA NNP Surgical
] NNP Surgical
) ) Surgical
and CC None
stent JJ Surgical
placement NN Surgical
IntraCoil NNP Surgical
stent NN Surgical
PTA NNP Surgical
. . Surgical
conventional JJ Surgical
balloon NN Surgical
angioplasty NN Surgical
, , None
stent JJ Surgical
placement NN Surgical
IntraCoil NNP Surgical
stent NN Surgical
PTA NNP Surgical
stent NN Physical
PTA NNP Physical
provisional JJ Physical
stent JJ Physical
implantation NN Physical
-DOCSTART- -X- N

intensive JJ Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
LNH-84 NNP Pharmocological
) ) Pharmocological
three CD None
or CC None
four CD None
courses NNS None
of IN None
doxorubicin NN Pharmocological
, , None
75 CD None
mg/m2 NN None
; : None
cyclophosphamide NN Pharmocological
, , None
1,200 CD None
mg/m2 NN None
; : None
vindesine NN Pharmocological
, , None
2 CD None
mg/m2 NN None
x NN None
2 CD None
; : None
bleomycin NN Pharmocological
, , None
10 CD None
mg NN None
x NN None
2 CD None
; : None
and CC None
prednisolone NN Pharmocological
, , None
60 CD None
mg/m2 NN None
x NN None
5 CD None
( ( None
ACVB NNP None
) ) None
, , None
consolidation NN None
with IN None
high-dose JJ None
methotrexate NN Pharmocological
, , None
ifosfamide NN Pharmocological
, , None
etoposide RB Pharmocological
, , None
asparaginase NN Pharmocological
, , None
and CC None
cytarabine NN Pharmocological
, , None
and CC None
a DT None
randomized VBN None
late JJ None
intensification NN None
with IN None
two CD None
courses NNS None
of IN None
cytarabine NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
teniposide NN Pharmocological
, , None
bleomycin NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( None
AraCVmB NNP None
) ) None
. . None
-DOCSTART- -X- N

Gamma-hydroxybutyric JJ Pharmocological
acid NN Pharmocological
clomethiazole NN Pharmocological
Clomethiazole NNP Pharmocological
( ( Pharmocological
CLO NNP Pharmocological
) ) Pharmocological
Gamma-Hydroxybutyric JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
GHB NNP Pharmocological
) ) Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
-DOCSTART- -X- N

Transdermal NNP None
scopolamine NN Pharmocological
patch NN None
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
( ( None
TDS NNP None
) ) None
patch NN None
a DT None
placebo JJ Control
patch NN None
scopolamine NN Pharmocological
-DOCSTART- -X- N

testosterone NN Pharmocological
and CC None
a DT None
nutritional JJ Pharmocological
supplement NN Pharmocological
in IN None
combination NN None
testosterone NN Pharmocological
treatment NN None
nutritional JJ Pharmocological
supplement NN Pharmocological
Oral NNP None
testosterone NN Pharmocological
undecanoate NN Pharmocological
and CC None
an DT None
oral JJ None
nutritional JJ Pharmocological
supplement NN Pharmocological
alone RB None
or CC None
combined VBN None
combined VBN None
testosterone NN Pharmocological
and CC None
nutritional JJ Pharmocological
supplements NNS Pharmocological
no-treatment JJ None
testosterone-treated JJ Pharmocological
supplement-treated JJ Pharmocological
no-treatment JJ None
combined-treatment JJ Pharmocological
combined VBN None
treatment NN None
with IN None
testosterone NN Pharmocological
and CC None
nutritional JJ Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

tailored VBN Educational
intervention NN Educational
promote VB Physical
sun NN Physical
protection NN Physical
-DOCSTART- -X- N

dietary JJ Pharmocological
fibre NN Pharmocological
source NN Pharmocological
soluble JJ Pharmocological
dietary JJ Pharmocological
fibre NN Pharmocological
meals NNS Pharmocological
oat JJ Pharmocological
powder NN Pharmocological
rye NN Pharmocological
bran NN Pharmocological
sugar JJ Pharmocological
beet NN Pharmocological
fibre NN Pharmocological
a DT None
mixture NN Other
of IN None
these DT None
three CD None
fibres NNS None
or CC None
no DT None
added JJ Control
fibre NN Control
( ( Control
control NN Control
) ) Control
carbohydrates NNS Other
. . Other
Meals NNP Pharmocological
with IN Pharmocological
rye NN Pharmocological
bran NN Pharmocological
Oat NNP Pharmocological
powder NN Pharmocological
oat NN Pharmocological
powder NN Pharmocological
meal NN Pharmocological
meal NN Control
. . Pharmocological
dietary JJ Pharmocological
fibre-rich JJ Pharmocological
meals NNS Pharmocological
-DOCSTART- -X- N

more RBR None
intensive JJ Pharmocological
( ( Pharmocological
MI NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
less RBR Pharmocological
intensive JJ Pharmocological
( ( Pharmocological
LI NNP Pharmocological
) ) Pharmocological
belatacept IN Pharmocological
immunosuppression NN Pharmocological
regimen NNS Pharmocological
, , None
or CC None
cyclosporine VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

Induction NNP Pharmocological
chemotherapy NN Pharmocological
induction VB None
chemotherapy NN Pharmocological
, , None
consisting VBG None
of IN None
bleomycin NN Pharmocological
( ( None
10 CD None
mg/m2/day NN None
in IN None
continuous JJ None
infusion NN None
from IN None
day NN None
1 CD None
to TO None
day NN None
5 CD None
) ) None
, , None
methotrexate NN Pharmocological
( ( None
120 CD None
mg/m2 NN None
on IN None
day NN None
2 CD None
) ) None
followed VBN None
by IN None
folinic JJ Pharmocological
acid NN Pharmocological
, , None
5-fluorouracil JJ Pharmocological
( ( None
5 CD None
FU NNP None
) ) None
( ( None
600 CD None
mg/m2 NN None
on IN None
day NN None
2 CD None
) ) None
, , None
and CC None
cisplatin NN Pharmocological
( ( None
120 CD None
mg/m2 NN None
on IN None
day NN None
4 CD None
) ) None
every DT None
4 CD None
weeks NNS None
for IN None
a DT None
total NN None
of IN None
three CD None
cycles NNS None
followed VBN None
by IN None
definitive JJ None
locoregional JJ None
treatment NN None
versus IN None
locoregional JJ None
treatment NN None
alone RB None
. . None
( ( None
radiotherapy JJ Surgical
+/- JJ None
surgery NN Surgical
) ) None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

sublingual JJ Pharmocological
fentanyl NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
fast-acting JJ Pharmocological
opioid NN Pharmocological
fentanyl NN Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
( ( Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
ODT NNP Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
fentanyl NN Pharmocological
ODT NNP Pharmocological
-DOCSTART- -X- N

metoclopramide RB Pharmocological
either DT Pharmocological
5 CD Pharmocological
% NN Pharmocological
D-glucose NNP Pharmocological
( ( Pharmocological
placebo NN Control
) ) Pharmocological
or CC Pharmocological
ANF NNP Pharmocological
pmol JJ Pharmocological
Metoclopramide NNP Pharmocological
ANF NNP Pharmocological
3 CD Pharmocological
-DOCSTART- -X- N

doxepin NN Pharmocological
bupropion NN Pharmocological
bupropion NN Pharmocological
doxepin VB Pharmocological
placebo NN Control
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
-DOCSTART- -X- N

standard NN Educational
wound NN Educational
care NN Educational
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
( ( Physical
HBOT NNP Physical
) ) Physical
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
plus CC Physical
standard NN Physical
wound NN Physical
care NN Physical
standard NN Physical
wound NN Physical
care NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
ongoing VBG Educational
wound NN Educational
care NN Educational
hyperbaric JJ None
oxygen NN None
therapy NN None
hyperbaric JJ None
oxygen NN None
therapy NN None
-DOCSTART- -X- N

-DOCSTART- -X- N

Co-administration NN None
of IN None
pethidine NN Pharmocological
and CC None
clonidine NN Pharmocological
: : None
pethidine NN Pharmocological
0.75 CD None
mg NN None
kg-1 NN None
and CC None
clonidine NN Pharmocological
75 CD None
micrograms NNS None
0.5 CD Pharmocological
% NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
. . Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
with IN None
morphine JJ Pharmocological
( ( None
pethidine-clonidine JJ Pharmocological
: : None
bupivacaine NN Pharmocological
: : None
bupivacaine JJ Pharmocological
alone NN Pharmocological
bupivacaine NN Pharmocological
and CC None
morphine NN Pharmocological
-DOCSTART- -X- N

acetylsalicylic JJ Pharmocological
acid NN Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ASA NNP Pharmocological
) ) Pharmocological
versus NN None
placebo NN Control
ASA NNP Pharmocological
placebo JJ Control
-DOCSTART- -X- N

-DOCSTART- -X- N

stapled VBN Surgical
technique NN Surgical
with IN Surgical
the DT Surgical
well-accepted JJ Surgical
conventional JJ Surgical
Stapled NNP Surgical
hemorrhoidectomy NN Surgical
-DOCSTART- -X- N

loop NN Surgical
vs. FW None
holder NN Surgical
techniques NNS Surgical
. . None
holder NN Surgical
versus IN Surgical
the DT Surgical
paper NN Surgical
loop NN Surgical
technique NN Surgical
. . None
bitewing NN None
holder NN Surgical
and CC Surgical
paper NN Surgical
loop NN Surgical
techniques NNS Surgical
. . None
bitewing NN Surgical
technique NN Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
and CC Surgical
holder NN Surgical
techniques NNS Surgical
-DOCSTART- -X- N

Flow NNP Other
cytometry NN Other
colony-stimulating NN Pharmocological
factor NN Pharmocological
[ IN Pharmocological
G-CSF NNP Pharmocological
] NNP Pharmocological
) ) Pharmocological
and CC None
autologous JJ Pharmocological
stem NN Pharmocological
cell NN Pharmocological
support NN Pharmocological
. . None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

moxifloxacin NN Pharmocological
moxifloxacin NN Pharmocological
400-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
moxifloxacin NN Pharmocological
. . None
moxifloxacin JJ Pharmocological
-DOCSTART- -X- N

alfuzosin NN Pharmocological
alfuzosin NN Pharmocological
placebo-controlled JJ Control
alfuzosin NN Pharmocological
or CC Control
matching VBG Control
placebo NN Control
alfuzosin NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Olanzapine NNP Pharmocological
versus NN None
haloperidol NN Pharmocological
neuroleptics NNS Pharmocological
Atypical JJ Pharmocological
neuroleptics NNS Pharmocological
olanzapine NN Pharmocological
haloperidol NN Pharmocological
open JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
olanzapine NN Pharmocological
or CC None
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
olanzapine NN Pharmocological
olanzapine NN Pharmocological
-DOCSTART- -X- N

RRR-alpha-tocopheryl NNP Pharmocological
acetate NN Pharmocological
and CC None
fish JJ Pharmocological
oil NN Pharmocological
RRR-alpha-tocpheryl NNP Pharmocological
acetate NN Pharmocological
( ( Pharmocological
alpha-tocopheryl JJ Pharmocological
acetate NN Pharmocological
) ) Pharmocological
and CC None
hormone-replacement JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
) ) None
alpha-tocopheryl JJ Pharmocological
acetate JJ Pharmocological
placebo NN Control
alpha-tocopheryl JJ Pharmocological
-DOCSTART- -X- N

cyclosporin VB Pharmocological
A DT Pharmocological
or CC None
methotrexate NN Pharmocological
cyclosporin VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CSA NNP Pharmocological
) ) Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
CSA NNP Pharmocological
and CC None
MTX NNP Pharmocological
in IN None
combination NN None
single-agent JJ None
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
MTX NNP Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Human NNP Physical
recombinant JJ Physical
GM-CSF NNP Physical
for IN None
14 CD None
days NNS None
after IN None
allogeneic JJ None
matched VBD None
sibling VBG None
bone NN None
marrow NN None
transplantation NN None
. . None
GM NNP Physical
CSF NNP Physical
GM-CSF NNP Pharmocological
placebo NN Control
GM-CSF NNP Pharmocological
GM NNP Pharmocological
CSF NNP Pharmocological
-DOCSTART- -X- N

Physostigmine JJ Pharmocological
physostigmine NN Pharmocological
scopolamine NN Pharmocological
Propofol NNP Pharmocological
physostigmine NN Pharmocological
scopolamine NN Pharmocological
-DOCSTART- -X- N

Codeine/acetaminophen NNP Pharmocological
hydrocodone/acetaminophen JJ Pharmocological
combination NN Pharmocological
acetaminophen VBP Pharmocological
. . None
codeine NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
in IN None
combination NN Pharmocological
with IN Pharmocological
acetaminophen NN Pharmocological
. . None
codeine NN Pharmocological
phosphate NN Pharmocological
versus IN None
hydrocodone NN Pharmocological
bitartrate NN Pharmocological
acetaminophen NN Pharmocological
of IN None
codeine/acetaminophen NN None
( ( None
C/A NNP None
) ) None
or CC None
hydrocodone/acetaminophen NN None
( ( None
H/A NNP None
) ) None
received VBD None
C/A NNP None
received VBD None
H/A NNP None
. . None
received VBD None
C/A NNP None
, , None
with IN None
H/A NNP None
, , None
the DT None
C/A NNP None
and CC None
H/A NNP None
between IN None
C/A NNP None
and CC None
H/A NNP None
-DOCSTART- -X- N

Lactobacillus NNP Pharmocological
plantarum NN Pharmocological
CECT7315 NNP Pharmocological
and CC Pharmocological
CECT7316 NNP Pharmocological
influenza JJ Pharmocological
vaccination NN Pharmocological
Lactobacillus NNP Pharmocological
plantarum NN Pharmocological
CECT NNP Pharmocological
7315/7316 CD Pharmocological
placebo-controlled JJ Control
trivalent JJ Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
A/Wisconsin/67/2005 NNP Pharmocological
NYMC NNP Pharmocological
X-161B NNP Pharmocological
( ( Pharmocological
H3N2 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
A/Solomon NNP Pharmocological
Islands/3/2006 NNP Pharmocological
( ( Pharmocological
H1N1 NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
B/Malaysia/2506/2004 NNP Pharmocological
) ) Pharmocological
L. NNP Pharmocological
plantarum NN Pharmocological
CECT NNP Pharmocological
7315/7316 CD Pharmocological
L. NNP Pharmocological
plantarum NN Pharmocological
CECT NNP Pharmocological
7315/7316 CD Pharmocological
placebo NN Control
powered VBN Control
skim JJ Control
milk NN Control
) ) Control
. . Control
L. NNP Pharmocological
plantarum NN Pharmocological
CECT NNP Pharmocological
7315/7316 CD Pharmocological
influenza JJ Pharmocological
vaccination NN Pharmocological
L. NNP Pharmocological
plantarum NN Pharmocological
CECT7315/7316 NNP Pharmocological
influenza VB Pharmocological
vaccination NN Pharmocological
-DOCSTART- -X- N

implantable JJ Surgical
cardioverter-defibrillator JJ Surgical
therapy NN Surgical
implantable JJ Surgical
cardioverter-defibrillators NNS Surgical
ICD NNP Surgical
ICD NNP Surgical
standard VB Control
medical JJ Control
therapy NN Control
-DOCSTART- -X- N

physiotherapy JJ Physical
management NN Physical
placebo NN Control
multimodal JJ Physical
physiotherapy NN Physical
programme NN Physical
including VBG None
taping VBG Physical
, , None
exercises NNS Physical
, , None
and CC None
massage NN Physical
placebo NN Control
Physiotherapy NNP Physical
and CC None
placebo JJ Control
Physiotherapy NNP Physical
included VBD Physical
exercise NN Physical
, , None
massage NN Physical
, , None
taping VBG Physical
, , None
and CC None
mobilisation NN Physical
, , None
followed VBN None
by IN None
12 CD None
weeks NNS None
of IN None
self JJ None
management NN None
. . None
Placebo NNP Control
sham VBN Control
ultrasound JJ Control
and CC Control
light JJ Control
application NN Control
of IN Control
a DT Control
non-therapeutic JJ Control
gel NN Control
, , Control
followed VBN Control
by IN Control
no DT Control
treatment NN Control
. . None
physiotherapy NN Physical
programme NN Physical
-DOCSTART- -X- N

Ribavirin JJ Pharmocological
peginterferon VB Pharmocological
alpha-2a JJ Pharmocological
180 CD Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
fentanyl/bupivacaine JJ Pharmocological
assigned VBN None
to TO None
receive VB None
either DT None
fentanyl NN Pharmocological
( ( None
10 CD None
micrograms/mL NN None
) ) None
or CC None
a DT None
fentanyl/bupivacaine NN Pharmocological
( ( None
0.1 CD None
% NN None
) ) None
mixture NN None
epidurally RB None
corresponding VBG None
to TO None
the DT None
dermatome NN None
of IN None
the DT None
surgical JJ None
incision NN None
in IN None
a DT None
double-blind JJ None
fashion NN None
for IN None
the DT None
The DT None
infusion NN None
was VBD None
titrated VBN None
for IN None
each DT None
patient NN None
to TO None
the DT None
rate NN None
required VBN None
for IN None
pain NN None
relief NN None
during IN None
forced VBN None
inspiration NN None
( ( None
pain NN None
score NN None
< NN None
or CC None
= $ None
2 CD None
, , None
maximum JJ None
10 CD None
) ) None
. . None
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
-DOCSTART- -X- N

Online NNP Other
conductivity NN Other
monitoring NN Other
: : None
reduced JJ Other
dialysate NN Other
conductivity NN Other
. . None
Relatively RB Other
low JJ Other
dialysate NN Other
conductivity NN Other
( ( Other
Cndi NNP Other
) ) Other
controlled JJ None
reduction NN Other
of IN Other
Cndi NNP Other
. . Other
reduction NN Other
of IN Other
Cndi NNP Other
Reduction NN Other
in IN Other
Cndi NNP Other
-DOCSTART- -X- N

topiroxostat NN Pharmocological
new JJ Pharmocological
xanthine JJ Pharmocological
oxidase NN Pharmocological
inhibitor NN Pharmocological
topiroxostat NN Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
topiroxostat NN Pharmocological
180 CD None
mg NN None
) ) None
, , None
moxifloxacin FW None
( ( None
400 CD None
mg NN None
) ) None
or CC None
placebo NN None
in IN None
prolonged VBN None
by IN None
moxifloxacin NN None
, , None
of IN None
which WDT None
Moxifloxacin NNP None
can MD None
be VB None
-DOCSTART- -X- N

-DOCSTART- -X- N

Family RB Educational
education NN Educational
family NN Educational
treatments NNS Educational
patient NN Educational
and CC Educational
family NN Educational
education NN Educational
family NN Educational
education NN Educational
control NN Control
group NN None
. . None
Family NNP Educational
education NN Educational
-DOCSTART- -X- N

Pre-bent JJ Physical
instruments NNS Physical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
versus IN Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
: : Surgical
single-incision NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
SILS NNP Surgical
) ) Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
CLS NNP Surgical
) ) Surgical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

epigallocatechin-3-gallate NN Pharmocological
Epigallocatechin-3-gallate NNP Pharmocological
( ( Pharmocological
EGCG NNP Pharmocological
) ) Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
w/w NN Pharmocological
of IN Pharmocological
EGCG NNP Pharmocological
. . Pharmocological
EGCG NNP Pharmocological
cream NN Pharmocological
vehicle NN Pharmocological
control NN Pharmocological
cream NN Pharmocological
EGCG NNP Pharmocological
vehicle NN Other
treated VBN Other
EGCG NNP None
treated VBD None
EGCG NNP None
treated VBD None
EGCG NNP None
vs. FW None
vehicle-treated JJ None
skin NN None
< NNP None
0.005 CD None
) ) None
. . None
EGCG NNP None
topical JJ None
-DOCSTART- -X- N

pharmacological JJ Pharmocological
blood NN Pharmocological
pressure NN Pharmocological
elevation NN Pharmocological
sympathomimetic JJ None
etilefrine NN None
placebo-controlled JJ Control
Etilefrine NNP Pharmocological
-DOCSTART- -X- N

Org NNP Pharmocological
2766 CD Pharmocological
20 CD None
mg NNS None
Org JJ Pharmocological
2766 CD Pharmocological
( ( None
synthetic JJ None
analog NN None
of IN None
ACTH NNP None
4-9 JJ None
) ) None
/day NN None
during IN None
4 CD None
weeks NNS None
, , None
or CC None
placebo NN None
in IN None
a DT None
randomly NN None
assigned VBN None
sequence NN None
. . None
were VBD None
monitored VBN None
by IN None
and CC None
by IN None
by IN None
parents NNS None
and CC None
teachers NNS None
. . None
-DOCSTART- -X- N

alcohol NN Educational
dependence NN Educational
Concurrent NNP Educational
alcohol NN Educational
dependence NN Educational
( ( Educational
AD NNP Educational
) ) Educational
contingency JJ Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
AD NNP Educational
, , Educational
randomized VBN Educational
to TO Educational
standard VB Educational
care NN Educational
( ( Educational
SC NNP Educational
) ) Educational
with IN Educational
or CC Educational
without IN Educational
CM NNP Educational
. . Educational
AD NNP Educational
AD NN Educational
non-AD JJ Educational
CM NNP Educational
SC NNP Educational
AD NNP Educational
AD NNP Educational
non-AD JJ Educational
-DOCSTART- -X- N

sumatriptan VB Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
agonist NN Pharmocological
, , Pharmocological
sumatriptan NN Pharmocological
sumatriptan NN Pharmocological
placebo NN Control
sumatriptan VB Pharmocological
. . Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
receptor NN Pharmocological
-DOCSTART- -X- N

Double-pulse JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
dpTMS NN Physical
) ) Physical
was VBD Physical
used VBN Physical
to TO Physical
examine VB Physical
inhibition NN Physical
by IN Physical
means NNS Physical
of IN Physical
short-interval JJ Physical
intracortical JJ Physical
inhibition NN Physical
( ( Physical
SICI NNP Physical
) ) Physical
of IN Physical
the DT Physical
contralateral JJ Physical
primary JJ Physical
motor NN Physical
cortex NN Physical
-DOCSTART- -X- N

bifidobacterium NN Pharmocological
breve VBP Pharmocological
Bifidobacterium NNP Pharmocological
breve NN Pharmocological
( ( Pharmocological
B. NNP Pharmocological
breve VBP Pharmocological
) ) Pharmocological
supplements NNS Pharmocological
three CD None
groups NNS None
: : None
Group NNP None
A NNP None
and CC None
B NNP None
received VBD None
a DT None
dose NN None
of IN None
1.6 CD None
x NNS None
10 CD None
( ( None
8 CD None
) ) None
cells NNS None
of IN None
B. NNP None
breve VBP None
supplement NN None
twice RB None
a DT None
day NN None
, , None
commencing VBG None
either CC None
from IN None
several JJ None
hours NNS None
after IN None
birth NN None
( ( None
group NN None
A NNP None
) ) None
or CC None
24 CD None
h NN None
after IN None
birth NN None
( ( None
group NN None
B NNP None
) ) None
. . None
control NN Control
group NN Control
no DT None
supplement NN None
. . None
-DOCSTART- -X- N

total JJ Other
hip NN Other
bone NN Other
mineral JJ Other
density NN Other
-DOCSTART- -X- N

plasma-derived JJ Pharmocological
heat-inactivated JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
CLB NNP Pharmocological
) ) Pharmocological
plasma-derived JJ Pharmocological
heat-inactivated JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
CLB NNP Pharmocological
) ) Pharmocological
three CD None
3-micrograms JJ None
doses NNS None
of IN None
heat-inactivated JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
surface NN Pharmocological
antigen NN Pharmocological
( ( Pharmocological
HBsAg NNP Pharmocological
) ) Pharmocological
at IN None
one-month JJ None
intervals NNS None
of IN None
five CD None
different JJ None
dosages NNS None
of IN None
the DT None
vaccine NN None
-DOCSTART- -X- N

Phytase NNP Pharmocological
and CC None
1alpha-hydroxycholecalciferol JJ Pharmocological
supplementation NN Pharmocological
phytase NN Pharmocological
and CC None
1alpha-OHD3 JJ Pharmocological
Ca- NNP Pharmocological
and CC Pharmocological
P-deficient NNP Pharmocological
diets NNS Pharmocological
. . None
-DOCSTART- -X- N

WHO/ISH NNP Pharmocological
risk NN Pharmocological
stratification NN Pharmocological
scheme NN Pharmocological
computer NN Other
program NN Other
-DOCSTART- -X- N

human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
: : Pharmocological
intravenous JJ Pharmocological
human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
hEGF NN Pharmocological
) ) Pharmocological
cetraxate VB Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
CH NNP Pharmocological
) ) Pharmocological
EGF NNP Pharmocological
CH NNP Pharmocological
. . Pharmocological
hEGF NN Pharmocological
hydroxypropyl NN Pharmocological
cellulose NN Pharmocological
EGF NNP Pharmocological
EGF NNP Pharmocological
-DOCSTART- -X- N

multi-faceted JJ Physical
intervention NN Physical
adaptive JJ Surgical
oral JJ Surgical
hygiene NN Surgical
devices NNS Surgical
orofacial JJ Physical
exercise NN Physical
multifaceted VBN Physical
oral JJ Physical
health NN Physical
intervention NN Physical
usual JJ Control
dental JJ Control
care NN Control
Oral-B? NNP Physical
oscillating-rotating-pulsating NN Physical
toothbrush NN Physical
and CC None
a DT None
Reach? NNP Physical
Access? NNP Physical
Flosser NNP Physical
that WDT None
orofacial JJ None
exercises NNS None
were VBD None
of IN None
adaptive JJ Surgical
devices NNS Surgical
and CC None
orofacial JJ Physical
exercise NN Physical
to TO None
of IN None
manual JJ Control
toothbrushing NN Control
and CC None
finger-held JJ Control
flossing NN Control
. . None
Recommending VBG None
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
methylprednisolone NN Pharmocological
methylprednisolone NN Pharmocological
cyclophosphamide NN Pharmocological
IV NNP Pharmocological
MP NNP Pharmocological
bimonthly RB Pharmocological
-DOCSTART- -X- N

weight-bearing JJ Physical
versus NN None
nonweight-bearing JJ Physical
exercise NN Physical
weight-bearing NN Physical
( ( Physical
WB NNP Physical
) ) Physical
exercise NN Physical
nonweight-bearing JJ Physical
( ( Physical
NWB NNP Physical
) ) Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
, , None
NWB NNP Physical
exercise NN Physical
control NN Control
group NN Control
( ( Control
no DT Control
exercise NN Control
) ) Control
. . None
WB NNP Physical
exercise NN Physical
and CC None
NWB NNP Physical
exercise NN Physical
groups NNS Physical
underwent VBD None
8-week JJ Physical
knee NN Physical
extension-flexion NN Physical
exercise NN Physical
program NN Physical
. . None
WB NNP Physical
exercise NN Physical
( ( Physical
WB NNP Physical
NWB NNP Physical
) ) None
NWB NNP Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
-DOCSTART- -X- N

received VBD None
7 CD None
weeks NNS None
wheelchair JJ Physical
training NN Physical
( ( None
3 CD None
week NN None
( ( None
-1 NN None
) ) None
, , None
70 CD None
min NN None
) ) None
at IN None
a DT None
low JJ None
intensity NN None
( ( None
30 CD None
% NN None
of IN None
the DT None
heart NN None
rate NN None
reserve NN None
) ) None
, , None
whereas IN None
the DT None
control NN Educational
group NN None
did VBD Educational
not RB Educational
receive VB Educational
training NN Educational
. . None
During IN None
pre- JJ None
and CC None
post-tests NNS None
, , None
submaximal JJ None
exercise NN None
was VBD None
performed VBN None
on IN None
a DT None
stationary JJ None
wheelchair NN Physical
ergometer NN None
at IN None
fixed JJ None
levels NNS None
of IN None
power NN None
output NN None
. . None
were VBD None
measured VBN None
. . None
-DOCSTART- -X- N

entacapone NN Pharmocological
Entacapone NNP Pharmocological
( ( Pharmocological
OR-611 NNP Pharmocological
) ) Pharmocological
, , None
a DT None
novel JJ Pharmocological
COMT NNP Pharmocological
inhibitor NN Pharmocological
levodopa/50 JJ Pharmocological
carbidopa NN Pharmocological
placebo NN Control
entacapone NN Pharmocological
. . None
-DOCSTART- -X- N

liu NN Pharmocological
wei NN Pharmocological
di NN Pharmocological
huang NN Pharmocological
jin NN Pharmocological
gui NN Pharmocological
shen NN Pharmocological
qi JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Liu NNP Pharmocological
Wei NNP Pharmocological
Di NNP Pharmocological
Huang NNP Pharmocological
Jin NNP Pharmocological
Gui NNP Pharmocological
Shen NNP Pharmocological
Qi NNP Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
-DOCSTART- -X- N

early JJ Physical
rehabilitation NN Physical
protocol NN Physical
-DOCSTART- -X- N

sublingual JJ Pharmocological
and CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
or CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
400 CD Pharmocological
microg NN Pharmocological
misoprostol NN Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
misoprostol NN Pharmocological
Vaginal NNP Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

trandolapril JJ Pharmocological
hydrochlorothiazide VB Pharmocological
single-blind JJ None
placebo NN Control
trandolapril JJ Pharmocological
hydrochlorothiazide RB Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
or CC None
the DT None
combination NN None
-DOCSTART- -X- N

Panax NNP Pharmocological
quinquefolius NN Pharmocological
( ( Pharmocological
American NNP Pharmocological
ginseng NN Pharmocological
) ) Pharmocological
American JJ Pharmocological
ginseng NN Pharmocological
( ( Pharmocological
Panax NNP Pharmocological
quinquefolius RB Pharmocological
) ) Pharmocological
American JJ Pharmocological
ginseng NN Pharmocological
placebo VB Control
American JJ Pharmocological
ginseng NN Pharmocological
. . Pharmocological
placebo NN Control
placebo NN Control
ginseng NN Pharmocological
placebo NN Control
. . Control
American JJ Pharmocological
ginseng NN Pharmocological
American NNP Pharmocological
ginseng NN Pharmocological
-DOCSTART- -X- N

Holter NNP Physical
electrocardiography NN Physical
continuous JJ Pharmocological
intravenous JJ Pharmocological
isosorbide NN Pharmocological
dinitrate NN Pharmocological
Holter NNP Physical
monitoring NN Physical
isosorbide JJ Pharmocological
dinitrate NN Pharmocological
Holter NNP Physical
monitoring NN Physical
-DOCSTART- -X- N

self-monitoring NN Physical
of IN Physical
blood NN Physical
pressure NN Physical
at IN Physical
home NN Physical
: : None
( ( Physical
HBP NNP Physical
) ) Physical
ambulatory VB Physical
( ( Physical
ABP NNP Physical
) ) Physical
HBP NNP Physical
ABP NNP Physical
HBP NNP Physical
ABP NNP Physical
HBP NNP Physical
( ( None
ABP NNP Physical
ABP NNP Physical
-DOCSTART- -X- N

Providing VBG Educational
Assistance NNP Educational
to TO Educational
Caregivers NNPS Educational
in IN Educational
Transition NNP Educational
( ( Educational
PACT NNP Educational
) ) Educational
program NN Educational
PACT NNP Other
program NN Other
PACT NNP Educational
case NN Educational
management NN Educational
in IN Educational
addition NN Educational
to TO Educational
their PRP$ Educational
usual JJ Educational
medical JJ Educational
and CC Educational
nursing NN Educational
home NN Educational
care NN Educational
. . None
usual JJ Educational
care NN Educational
. . None
PACT-type JJ Educational
intervention NN Educational
-DOCSTART- -X- N

Psychoeducational NNP Educational
group NN Educational
intervention NN Educational
psychoeducational JJ Educational
group NN Educational
intervention NN Educational
psychoeducational JJ Control
group NN Control
intervention NN Control
or CC None
a DT None
no-treatment JJ Control
control NN Control
group NN Control
psychoeducational JJ Educational
intervention NN Educational
-DOCSTART- -X- N

spinal JJ Physical
manipulation NN Physical
therapy NN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
fixed-point JJ Physical
spin NN Physical
reduction NN Physical
of IN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
and CC None
dialectical JJ Pharmocological
prescription NN Pharmocological
. . None
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
-DOCSTART- -X- N

patient JJ Educational
education NN Educational
and CC None
supervised VBD Physical
exercise NN Physical
patient JJ Educational
education NN Educational
alone RB Educational
patient JJ Educational
education NN Educational
and CC None
supervised VBD Other
exercise NN Other
patient JJ Educational
education NN Educational
alone RB Educational
Patient NNP Educational
education NN Educational
( ( Educational
PE NNP Educational
) ) Educational
. . None
Patient JJ Educational
education NN Educational
and CC None
supervised VBN Physical
exercise NN Physical
( ( None
PE+SE NNP None
) ) None
. . None
PE+SE NNP Physical
PE NNP Educational
PE NNP Educational
and CC None
SE NNP Physical
. . None
PE NNP Educational
program NN Educational
12-week JJ None
SE NNP None
program NN None
between IN None
PE+SE NNP None
vs NNP None
PE NNP None
alone RB None
. . None
Adding VBG None
SE NNP None
to TO None
PE NNP None
may MD None
-DOCSTART- -X- N

Isolated NNP Pharmocological
limb NN Pharmocological
perfusion NN Pharmocological
( ( Pharmocological
ILP NNP Pharmocological
) ) Pharmocological
with IN None
tumor NN Pharmocological
necrosis NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
TNF NNP Pharmocological
) ) Pharmocological
, , None
interferon JJ Pharmocological
gamma NN Pharmocological
, , None
and CC None
melphalan NN Pharmocological
( ( Pharmocological
M NNP Pharmocological
) ) Pharmocological
ILP NNP Pharmocological
with IN Pharmocological
TNF-alpha NNP Pharmocological
, , None
interferon NN Pharmocological
gamma NN Pharmocological
and CC None
M NNP Pharmocological
( ( Pharmocological
TNF/IFN/M NNP Pharmocological
) ) Pharmocological
or CC None
M NNP Pharmocological
alone RB None
iodine-131 JJ Pharmocological
albumin NN Pharmocological
. . Pharmocological
enzyme-linked JJ Pharmocological
immunosorbent NN Pharmocological
assay NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

dipeptidyl JJ Pharmocological
peptidase-4 JJ Pharmocological
inhibitor NN Pharmocological
PHX1149 NNP Pharmocological
PHX1149 NNP Pharmocological
PHX1149 NNP Pharmocological
( ( None
100 CD None
, , None
200 CD None
or CC None
400 CD None
mg NN None
) ) None
or CC None
placebo NN Control
; : None
-DOCSTART- -X- N

18F-FDG JJ None
PET/CT NNP None
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ Pharmocological
combination NN Pharmocological
Neo-ALTTO NNP None
( ( None
Neoadjuvant NNP Pharmocological
Lapatinib NNP Pharmocological
and/or VBZ None
Trastuzumab NNP Pharmocological
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ None
combination NN Pharmocological
. . None
anti-HER2 JJ Pharmocological
therapy NN Pharmocological
paclitaxel NN Pharmocological
. . Pharmocological
anti-HER2 JJ Pharmocological
therapies NNS Pharmocological
anti-HER2 JJ Pharmocological
treatment NN Pharmocological
. . Pharmocological
neoadjuvant JJ Pharmocological
trastuzumab NN Pharmocological
, , None
lapatinib NN Pharmocological
, , None
or CC None
their PRP$ None
combination NN Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
chemoradiotherapy NN Pharmocological
Preoperative NNP Physical
chemoradiotherapy NN Physical
radiotherapy VB Physical
-DOCSTART- -X- N

cardiovascular JJ Other
risk NN Other
assessment NN Other
-DOCSTART- -X- N

Coagulation NNP Pharmocological
factor NN Pharmocological
concentrate NN Pharmocological
clotting VBG Pharmocological
factor NN Pharmocological
concentrate NN Pharmocological
infusions NNS Pharmocological
concentrate VB Pharmocological
heparin NN Pharmocological
concentrate NN Pharmocological
alone RB None
heparin NN Pharmocological
. . Pharmocological
concentrate VBP Pharmocological
-DOCSTART- -X- N

Memantine NNP Pharmocological
add-on JJ None
to TO None
risperidone VB Pharmocological
memantine JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

web- JJ Educational
and CC Educational
a DT Educational
print-based JJ Educational
decision NN Educational
aid NN Educational
booklet NN Educational
interactive JJ Educational
website NN Educational
randomized VBN Educational
controlled JJ Educational
trials NNS Educational
( ( Educational
RCTs NNP Educational
) ) Educational
website NN Educational
-DOCSTART- -X- N

Yufeining VBG Pharmocological
Yufeining NNP Pharmocological
Yufeining VBG Pharmocological
pills NNS Pharmocological
control NN Control
group NN Control
was VBD Control
not RB Control
given VBN Control
any DT Control
medicine NN Control
. . Control
-DOCSTART- -X- N

Intravenous JJ Pharmocological
or CC Pharmocological
intramuscular JJ Pharmocological
teicoplanin NN Pharmocological
Teicoplanin NNP Pharmocological
teicoplanin NN Pharmocological
teicoplanin NN Pharmocological
teicoplanin NN Pharmocological
teicoplanin JJ Pharmocological
teicoplanin NN Pharmocological
teicoplanin NN Pharmocological
teicoplanin JJ Pharmocological
teicoplanin NN Pharmocological
teicoplanin JJ Pharmocological
-DOCSTART- -X- N

Questionnaire NNP Other
. . None
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
Kruskal-Wallis NNP Other
test NN Other
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
-DOCSTART- -X- N

perindopril-indapamide JJ Pharmocological
or CC None
placebo NN Control
. . None
perindopril-indapamide JJ Pharmocological
-DOCSTART- -X- N

long-term JJ Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
long-term JJ Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
vitamin JJ Pharmocological
E NN Pharmocological
Daily NNP None
dose NN None
of IN None
natural JJ Pharmocological
source NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
( ( None
400 CD None
IU NNP None
) ) None
or CC None
matching VBG None
placebo NN Control
. . None
vitamin NN Pharmocological
E NNP Pharmocological
placebo NN Control
vitamin NN Pharmocological
E NNP Pharmocological
long-term JJ Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Parent-mediated JJ Educational
communication-focused JJ Educational
treatment NN Educational
( ( Educational
Preschool NNP Educational
Autism NNP Educational
Communication NNP Educational
Trial NNP Educational
[ NNP Educational
PACT NNP Educational
] NNP Educational
) ) Educational
intervention NN Educational
treatment NN Control
as IN Control
usual JJ Control
PACT NNP Educational
intervention NN Educational
-DOCSTART- -X- N

B-type JJ Other
natriuretic JJ Other
peptide NN Other
diagnostic JJ Other
strategy NN Other
including VBG Other
point-of-care JJ Other
measurement NN Other
of IN Other
BNP NNP Other
standard JJ Control
assessment NN Control
without IN Control
BNP NNP Control
BNP NNP Other
levels NNS Other
-DOCSTART- -X- N

Acidform NNP Pharmocological
, , Pharmocological
an DT Pharmocological
acid-buffering JJ Pharmocological
, , Pharmocological
bioadhesive JJ Pharmocological
gel NN Pharmocological
. . Pharmocological
acid-buffering JJ Pharmocological
vaginal JJ Pharmocological
gel NN Pharmocological
( ( Pharmocological
Acidform NNP Pharmocological
) ) Pharmocological
without IN Pharmocological
or CC Pharmocological
with IN Pharmocological
nonoxynol-9 JJ Pharmocological
( ( Pharmocological
N-9 NNP Pharmocological
) ) Pharmocological
. . Pharmocological
N-9 NNP Pharmocological
Acidform NNP Pharmocological
without IN Pharmocological
N-9 NNP Pharmocological
. . Pharmocological
Acidform/N-9 JJ Pharmocological
Acidform VB Pharmocological
without IN Pharmocological
N-9 NNP Pharmocological
-DOCSTART- -X- N

donor NN Educational
recruitment NN Educational
brochure NN Educational
. . None
blood NN Educational
donor NN Educational
recruitment NN Educational
materials NNS Educational
brochures NNS Educational
: : None
a DT Educational
new JJ Educational
brochure NN Educational
addressing VBG Educational
common JJ Educational
donor NN Educational
concerns NNS Educational
and CC Educational
suggesting VBG Educational
specific JJ Educational
coping VBG Educational
strategies NNS Educational
, , None
2 CD None
) ) None
a DT None
standard JJ Educational
blood NN Educational
center NN Educational
brochure NN Educational
a DT Control
control JJ Educational
brochure NN Educational
on IN Educational
healthy JJ Educational
eating NN Educational
and CC Educational
exercise NN Educational
. . None
-DOCSTART- -X- N

Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
acupuncture NN Physical
group NN None
and CC None
the DT None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
injection NN Pharmocological
group NN Pharmocological
. . None
MSAT NNP Physical
and CC None
the DT None
NSAID NNP Pharmocological
injection NN Pharmocological
group NN Pharmocological
diclofenac NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Echocardiography NN Physical
natriuretic JJ None
peptide NN None
Carvedilol NN Pharmocological
-DOCSTART- -X- N

gluten- JJ Other
and CC Other
casein-free JJ Other
dietary JJ Other
intervention NN Other
gluten- JJ Other
and CC Other
casein-free JJ Other
diets NNS Other
dietary JJ Other
intervention NN Other
placebo NN Control
-DOCSTART- -X- N

leisure NN Educational
programme NN Educational
1-year JJ Educational
group NN Educational
leisure NN Educational
programme NN Educational
interaction NN Educational
with IN Educational
media NNS Educational
, , None
engagement NN Educational
in IN Educational
exercise NN Educational
, , None
playing VBG Educational
games NNS Educational
and CC Educational
doing VBG Educational
crafts NNS Educational
, , None
attending VBG Educational
events NNS Educational
, , None
and CC None
participating VBG Educational
in IN Educational
other JJ Educational
recreation NN Educational
activities NNS Educational
-DOCSTART- -X- N

Social NNP Educational
support NN Educational
general JJ Educational
and CC Educational
abstinence-specific JJ Educational
support NN Educational
, , Educational
both DT Educational
structural JJ Educational
and CC Educational
functional JJ Educational
abstinence-specific JJ Educational
abstinence-specific JJ Educational
-DOCSTART- -X- N

Prophylactic JJ Pharmocological
vs NN Pharmocological
therapeutic JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
Epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
prophylactic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
conservative JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
a DT Pharmocological
therapeutic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
if IN None
required VBN None
. . None
prophylactic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
therapeutic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
prophylactic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
therapeutic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
patch NN Pharmocological
. . Pharmocological
prophylactic JJ Pharmocological
epidural JJ Pharmocological
blood NN Pharmocological
-DOCSTART- -X- N

COMPASS NNP Educational
intervention NN Educational
-DOCSTART- -X- N

remifentanil NN Pharmocological
lidocaine NN Pharmocological
with IN Pharmocological
esmolol NN Pharmocological
. . None
remifentanil NN Pharmocological
lidocaine-esmolol JJ Pharmocological
0.9 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
10 CD Pharmocological
ml NN Pharmocological
and CC Pharmocological
remifentanil VB Pharmocological
1 CD Pharmocological
microg/kg NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
1.5 CD Pharmocological
mg/kg NN Pharmocological
and CC Pharmocological
esmolol $ Pharmocological
1.0 CD Pharmocological
mg/kg NN Pharmocological
. . None
thiopental JJ Pharmocological
sodium NN Pharmocological
rocuronium NN Pharmocological
remifentanil VBZ Pharmocological
lidocaine JJ Pharmocological
esmolol $ Pharmocological
-DOCSTART- -X- N

capsule NN Pharmocological
formulations NNS Pharmocological
. . Pharmocological
soft JJ Pharmocological
gelatin NN Pharmocological
capsule NN Pharmocological
formulations NNS Pharmocological
of IN Pharmocological
formulations NNS None
with IN None
different JJ None
in IN None
vitro NN None
burst NN None
times NNS None
dissolution NN None
rates NNS None
digoxin NN Pharmocological
-DOCSTART- -X- N

fenretinide NN Pharmocological
synthetic JJ Pharmocological
retinoid NN Pharmocological
fenretinide NN Pharmocological
fenretinide NN Pharmocological
( ( None
200 CD None
mg NNS None
day NN None
p.o NN None
. . None
for IN None
24 CD None
months NNS None
) ) None
or CC None
no DT Control
intervention NN Control
. . None
fenretinide JJ Pharmocological
-DOCSTART- -X- N

Secretin NNP Pharmocological
secretin JJ Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
vs. FW Pharmocological
saline NN Control
infusions NNS Control
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
vs. FW None
saline NN Control
infusions NNS Control
secretin NN Pharmocological
, , Pharmocological
porcine NN Pharmocological
or CC Pharmocological
synthetic JJ Pharmocological
-DOCSTART- -X- N

nicorandil JJ Pharmocological
nicorandil NN Pharmocological
nicorandil NN Pharmocological
or CC None
a DT None
placebo NN Pharmocological
nicorandil JJ Pharmocological
placebo NN Control
nicorandil JJ Pharmocological
placebo NN Control
nicorandil NN Pharmocological
nicorandil NN Pharmocological
placebo NN Control
nicorandil NNS Pharmocological
-DOCSTART- -X- N

fluticasone NN Pharmocological
propionate NN Pharmocological
powder NN Pharmocological
placebo NN Control
Fluticasone NNP Pharmocological
propionate NN Pharmocological
inhaled JJ Pharmocological
fluticasone NN Pharmocological
propionate NN Pharmocological
powder NN Pharmocological
fluticasone JJ Pharmocological
propionate NN Pharmocological
powder NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nebulized JJ Pharmocological
flunisolide NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
salbutamol NN Pharmocological
and CC Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
corticosteroids NNS Pharmocological
nebulized JJ Pharmocological
flunisolide NN Pharmocological
+ VBZ Pharmocological
salbutamol/ipratropium JJ Pharmocological
bromide NN Pharmocological
placebo NN Control
+ NNP None
salbutamol/ipratropium NN Control
bromide NN Control
. . None
flunisolide NN Pharmocological
placebo NN Control
flunisolide NN Pharmocological
placebo NN Control
flunisolide JJ Pharmocological
flunisolide NN Pharmocological
flunisolide RB Pharmocological
placebo NN Control
Nebulized NNP Pharmocological
flunisolide NN Pharmocological
nebulized JJ Pharmocological
salbutamol/ipratropium NN Pharmocological
bromide NN Pharmocological
-DOCSTART- -X- N

Psychosocial JJ Psychological
nursing NN Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
cognitive JJ Psychological
behavioral JJ Psychological
therapy NN Psychological
control NN Control
Psychosocial NNP Psychological
therapy NN Psychological
-DOCSTART- -X- N

cyclical JJ Pharmocological
medroxyprogesterone NN Pharmocological
placebo PDT Control
C21 NNP Pharmocological
progestogen NN Pharmocological
, , None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
four CD None
randomised VBN None
treatment NN None
phases NNS None
MPA NNP Pharmocological
2.5 CD None
mg NN None
, , None
MPA NNP Pharmocological
5 CD None
mg NN None
, , None
MPA NNP Pharmocological
10 CD None
mg NN None
and CC None
matching VBG None
placebo NN Control
, , None
taken VBN None
for IN None
the DT None
last JJ None
14 CD None
days NNS None
of IN None
each DT None
28 CD None
day NN None
treatment NN None
cycle NN None
. . None
CEE NNP None
progestogen NN Pharmocological
-DOCSTART- -X- N

potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
with IN None
those DT None
of IN None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
tonsillectomy NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
tonsillectomy NN Surgical
. . None
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
bipolar JJ Surgical
radiofrequency NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
and CC None
the DT None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
Potassium NNP Surgical
titanyl JJ Surgical
phosphate NN Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
-DOCSTART- -X- N

Moist NN Pharmocological
Exposed VBD Pharmocological
Burn NNP Pharmocological
Ointment NNP Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
dermaheal NN Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
( ( None
MEBO NNP Pharmocological
) ) None
MEBO NNP Pharmocological
Flammazine NNP Pharmocological
MEBO NNP Pharmocological
. . None
MEBO NNP Pharmocological
ointment NN Pharmocological
-DOCSTART- -X- N

intermittent JJ None
vaginal JJ None
administration NN None
of IN None
misoprostol NN Pharmocological
continuous JJ None
dinoprostone NN Pharmocological
vaginal JJ None
administration NN None
of IN None
misoprostol NN Pharmocological
( ( Pharmocological
Cytotec NNP Pharmocological
) ) Pharmocological
dinoprostone NN Pharmocological
( ( Pharmocological
Cervidil NNP Pharmocological
) ) Pharmocological
misoprostol NN Pharmocological
( ( Pharmocological
prostaglandin JJ Pharmocological
E1 NNP Pharmocological
) ) Pharmocological
dinoprostone NN Pharmocological
( ( Pharmocological
prostaglandin JJ Pharmocological
E2 NNP Pharmocological
) ) Pharmocological
misoprostol NN Pharmocological
misoprostol NN Pharmocological
Cervidil NNP Pharmocological
dinoprostone NN Pharmocological
misoprostol NN Pharmocological
dinoprostone NN Pharmocological
misoprostol-treated JJ Pharmocological
dinoprostone-treated JJ Pharmocological
misoprostol NN Pharmocological
dinoprostone NN Pharmocological
. . Pharmocological
misoprostol NN Pharmocological
dinoprostone NN Pharmocological
misoprostol-treated JJ Pharmocological
dinoprostone-treated JJ Pharmocological
misoprostol NN Pharmocological
misoprostol NN Pharmocological
dinoprostone NN Pharmocological
. . None
-DOCSTART- -X- N

monodisperse JJ Pharmocological
10 CD Pharmocological
microM NN Pharmocological
MMAD NNP Pharmocological
aerosol NN Pharmocological
of IN Pharmocological
H2SO4 NNP Pharmocological
nominal JJ None
concentration NN None
acid VB Control
or CC Control
control VB Control
equiosmolar JJ Control
NaCl NNP Control
aerosol NN Control
-DOCSTART- -X- N

verapamil NN Pharmocological
: : Pharmocological
placebo-controlled JJ Control
verapamil NN Pharmocological
Verapamil NNP Pharmocological
placebo NN Control
. . Control
placebo NN Control
verapamil JJ Pharmocological
Verapamil NNP Pharmocological
's POS Pharmocological
Verapamil NNP Pharmocological
verapamil NN Pharmocological
Verapamil NNP Pharmocological
-DOCSTART- -X- N

insertion NN Physical
vs. FW None
use NN Physical
Direct JJ Physical
trocar NN Physical
insertion NN Physical
Direct JJ Physical
trocar NN Physical
-DOCSTART- -X- N

( ( Other
13 CD Other
) ) Other
C-octanoic NNP Other
-DOCSTART- -X- N

Transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
with IN None
standard JJ None
intramuscular JJ None
opiate NN Pharmocological
analgesia NN Pharmocological
sham NN Physical
TENS NNP Physical
and CC None
active JJ Physical
TENS NNP Physical
groups NNS Physical
. . None
active JJ Physical
and CC Physical
sham JJ Physical
TENS NNP Physical
control NN Control
group NN Control
active JJ Physical
and CC Physical
sham JJ Physical
TENS NNP Physical
active JJ Physical
TENS NNP Physical
TENS NNP Physical
-DOCSTART- -X- N

physical JJ Psychological
and CC Psychological
emotional JJ Psychological
status NN Psychological
low-fat JJ Other
dietary JJ Other
pattern NN Other
intervention NN Educational
program NN Educational
( ( Educational
attending VBG Educational
sessions NNS Educational
and CC Educational
self-monitoring NN Educational
) ) Educational
. . Educational
dietary JJ Other
adherence NN Other
low-fat JJ Educational
intervention NN Educational
reduce VB Educational
total JJ Educational
fat JJ Educational
intake NN Educational
to TO Educational
20 CD Educational
% NN Educational
or CC Educational
less JJR Educational
of IN Educational
energy NN Educational
from IN Educational
fat JJ Educational
and CC Educational
to TO Educational
consume VB Educational
5 CD Educational
or CC Educational
more JJR Educational
fruit/vegetable JJ Educational
servings NNS Educational
daily RB Educational
and CC Educational
6 CD Educational
or CC Educational
more JJR Educational
grain JJ Educational
servings NNS Educational
daily RB Educational
. . Educational
dietary JJ Educational
intervention NN Educational
program NN Educational
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
therapy NN Pharmocological
Recombinant NNP Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHuEPO NN Pharmocological
) ) Pharmocological
rHuEPO NN Pharmocological
placebo NN Control
rHuEPO NN Pharmocological
rHuEPO VB Pharmocological
rHuEPO NN Pharmocological
-DOCSTART- -X- N

Warfarin NNP Pharmocological
warfarin NN Pharmocological
therapy NN None
warfarin NN Pharmocological
warfarin NN Pharmocological
warfarin NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

disease JJ Other
management NN Other
program NN Other
with IN Other
repetitive JJ Other
education NN Other
and CC None
telephone NN Other
monitoring NN Other
Education NNP Other
and CC Other
Monitoring NNP Other
control NN Control
. . Control
-DOCSTART- -X- N

galacto-oligosaccharides NNS Pharmocological
and CC None
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
LGG NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
galacto-oligosaccharides NNS Pharmocological
( ( Pharmocological
GOS NNP Pharmocological
) ) Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
+ NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
GOS NNP Pharmocological
-DOCSTART- -X- N

chronic JJ Pharmocological
sildenafil NN Pharmocological
therapy NN Pharmocological
Sildenafil NNP Pharmocological
sildenafil NN Pharmocological
placebo-controlled JJ Control
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil JJ Pharmocological
-DOCSTART- -X- N

dexanabinol NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

Whole-body JJ Other
CT NNP Other
screening NN Other
: : None
scan JJ None
delay NN None
and CC None
contrast NN Pharmocological
injection NN Pharmocological
contrast-enhanced JJ Other
whole-body NN Other
computed VBN Other
tomography NN Other
( ( Other
CT NNP Other
) ) Other
. . Other
protocol NN None
A-scan JJ None
delay NN None
of IN None
65 CD None
s NNS None
after IN None
starting VBG None
contrast NN Pharmocological
injection NN Pharmocological
over IN None
30 CD None
s NNS None
; : None
protocol CC None
B-105 NNP None
and CC None
70 CD None
s NN None
; : None
and CC None
protocol VB None
C-145 NNP None
and CC None
110 CD None
s NN None
protocol NN None
C NNP None
whole-body JJ Other
CT NNP Other
. . Other
-DOCSTART- -X- N

-DOCSTART- -X- N

brachial-basilic JJ Physical
( ( Physical
BB NNP Physical
) ) Physical
AVF NNP Physical
prosthetic JJ Physical
brachial-antecubital JJ Physical
forearm NN Physical
loop NN Physical
access NN Physical
BB-AVF NNP Physical
or CC Physical
prosthetic JJ Physical
brachial-antecubital JJ Physical
forearm NN Physical
loop NN Physical
access NN Physical
. . Physical
-DOCSTART- -X- N

Salbutamol NNP Pharmocological
mist NN Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
saline NN Control
saline NN Control
mist NN Pharmocological
oxygen NN Pharmocological
Salbutamol NNP Pharmocological
-DOCSTART- -X- N

antihypertensive JJ Pharmocological
agents NNS Pharmocological
-- : None
use NN None
nonmedicamentous JJ Pharmocological
non-medicamentous JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
CNT NNP Pharmocological
) ) Pharmocological
antihypertensive JJ Pharmocological
drugs NNS Pharmocological
non-medicamentously RB Pharmocological
antihypertensive JJ Pharmocological
drugs NNS Pharmocological
non-medicamentous JJ Pharmocological
therapeutic JJ Pharmocological
-DOCSTART- -X- N

motivational JJ Educational
music NN Educational
motivational JJ Educational
music NN Educational
( ( Educational
music NN Educational
that WDT Educational
stimulates VBZ Educational
or CC Educational
inspires VBZ Educational
physical JJ Educational
activity NN Educational
) ) Educational
6-minute JJ None
run NN None
at IN None
peak NN None
oxygen NN None
consumption NN None
speed NN None
and CC None
without IN None
music NN None
. . None
-DOCSTART- -X- N

sibutramine NN Pharmocological
sibutramine-induced JJ Pharmocological
sibutramine JJ Pharmocological
placebo NN Control
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine NN Pharmocological
-DOCSTART- -X- N

joint JJ Educational
attention NN Educational
or CC Educational
symbolic JJ Educational
play NN Educational
-DOCSTART- -X- N

person-centred JJ Educational
dementia NN Educational
care NN Educational
Dementia NNP Educational
Care NNP Educational
Mapping NNP Educational
( ( Educational
DCM NNP Educational
) ) Educational
VIPS NNP Educational
practice NN Educational
model NN Educational
( ( Educational
VPM NNP Educational
) ) Educational
dementia NN None
DCM NNP Educational
VPM NNP Educational
-DOCSTART- -X- N

four CD Physical
intermediate JJ Physical
layer NN Physical
treatments NNS Physical
four CD Other
different JJ Other
intermediate JJ Other
materials NNS Other
condensable JJ Other
composite NN Other
. . Other
fuchsin NN None
resin-modified JJ Other
glass NN Other
ionomer NN Other
cement NN Other
dentin NN Other
bonding NN Other
agent NN Other
alone RB Other
combination NN Other
with IN Other
flowable JJ Other
composite JJ Other
glass NN Physical
ionomer NN Physical
open JJ Physical
sandwich NN Physical
technique NN Physical
-DOCSTART- -X- N

Docosahexaenoic NNP Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
placebo-controlled JJ Control
docosahexaenoic JJ Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
or CC Control
placebo NN Control
( ( Control
olive JJ Control
oil NN Control
) ) Control
. . Control
-DOCSTART- -X- N

Laser NNP Surgical
conization NN Surgical
cold JJ Surgical
knife NN Surgical
conization NN Surgical
. . Surgical
cold JJ Surgical
knife NN Surgical
technique NN Surgical
or CC None
the DT None
carbon NN Surgical
dioxide NN Surgical
laser NN Surgical
scalpel NN Surgical
. . None
cold JJ Surgical
knife NN Surgical
cold JJ Surgical
knife NN Surgical
laser JJR Surgical
cold JJ Surgical
knife NN Surgical
-DOCSTART- -X- N

diltiazem NN Pharmocological
, , Pharmocological
nitroglycerin NN Pharmocological
, , Pharmocological
or CC Pharmocological
sodium NN Pharmocological
nitroprusside RB Pharmocological
. . None
Diltiazem NNP Pharmocological
Nitroglycerin NNP Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

consuming VBG None
600 CD Educational
ml NN Educational
of IN Educational
water NN Educational
on IN None
consuming VBG None
water NN Educational
( ( Educational
W NNP Educational
) ) Educational
, , None
salt-water JJ Educational
( ( Educational
carbohydrate-electrolyte JJ Educational
solution NN Educational
with IN Educational
3 CD Educational
% NN Educational
or CC Educational
light JJ Educational
carbohydrate NN Educational
( ( Educational
CES NN Educational
with IN Educational
6 CD Educational
% NN Educational
carbohydrate NN Educational
( ( Educational
W NNP None
CES NNP None
-DOCSTART- -X- N

Somatostatin NNP Pharmocological
and CC Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
vs. FW Pharmocological
ranitidine NN Pharmocological
somatostatin-UCB NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
Somatostatin NNP Pharmocological
Somatostatin NNP Pharmocological
-DOCSTART- -X- N

Enhanced NNP Educational
instruction NN Educational
using VBG Educational
choral JJ Educational
responding NN Educational
and CC Educational
effective JJ Educational
instructional JJ Educational
strategies NNS Educational
the DT Educational
use NN Educational
of IN Educational
choral JJ Educational
responding NN Educational
; : Educational
the DT Educational
use NN Educational
of IN Educational
student-to-student JJ Educational
responding NN Educational
; : Educational
the DT Educational
rotation NN Educational
of IN Educational
materials NNS Educational
every DT Educational
5 CD Educational
minutes NNS Educational
during IN Educational
the DT Educational
30-minute JJ Educational
group NN Educational
while IN Educational
teaching VBG Educational
2 CD Educational
to TO Educational
3 CD Educational
concepts NNS Educational
; : Educational
and CC Educational
the DT Educational
use NN Educational
of IN Educational
random NN Educational
, , Educational
unpredictable JJ Educational
trials NNS Educational
for IN Educational
student NN Educational
responding VBG Educational
. . Educational
-DOCSTART- -X- N

Diode NNP Physical
laser NN Physical
photocoagulation NN Physical
peripheral JJ Physical
cryotherapy NN Physical
Argon NNP Physical
laser NN Physical
indirect JJ Physical
ophthalmoscope NN Physical
photocoagulation NN Physical
cryotherapy VB Physical
diode NN Physical
lasers NNS Physical
argon NN Physical
laser NN Physical
ablative JJ Physical
therapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
cryotherapy-treated JJ Physical
cryotherapy-treated JJ Physical
laser-treated JJ Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
diode VB Physical
laser RBR Physical
peripheral JJ Physical
retinal JJ Physical
ablation NN Physical
cryotherapy NN Physical
-DOCSTART- -X- N

metformin NN Pharmocological
metformin NN Pharmocological
metformin NN Pharmocological
metformin NN Pharmocological
treatment NN None
( ( None
850 CD None
mg RB None
bid NN None
) ) None
with IN None
placebo NN Control
. . None
Metformin NNP Pharmocological
placebo NN Control
metformin NN Pharmocological
placebo NN Control
metformin VBZ Pharmocological
-DOCSTART- -X- N

This DT None
study NN None
investigated VBD None
whether IN None
instruction NN Other
that WDT Other
involves VBZ Other
comparing VBG Other
the DT Other
equal JJ Psychological
sign NN Psychological
with IN Other
other JJ Other
relational JJ Other
symbols NNS Other
is VBZ None
more RBR None
effective JJ None
at IN None
imparting VBG None
a DT None
than IN None
instruction NN Other
about IN Other
the DT Other
equal JJ Psychological
sign NN Psychological
alone RB Other
. . None
learned VBD Educational
about IN Educational
the DT Educational
greater JJR Educational
than IN Educational
, , Educational
less JJR Educational
than IN Educational
, , Educational
and CC Educational
equal JJ Psychological
signs NNS Psychological
and CC Educational
had VBD Educational
the DT Educational
opportunity NN Educational
to TO Educational
compare VB Educational
the DT Educational
inequality NN Educational
symbols VBZ Educational
with IN Educational
the DT Educational
equal JJ Psychological
sign NN Psychological
. . None
Students NNS None
in IN None
an DT None
equal JJ Psychological
sign NN Psychological
group NN Educational
learned VBD Educational
about IN Educational
the DT Educational
equal JJ Psychological
sign NN Psychological
only RB Educational
. . Educational
A NNP None
third JJ None
group NN None
of IN None
students NNS None
served VBD None
as IN None
a DT None
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

smokeless JJ Other
tobacco NN Other
group NN Educational
therapy NN Educational
: : Other
Smokeless NNP Other
tobacco NN Other
smokeless NN Other
tobacco NN Other
group NN Educational
support NN Educational
smokeless NN Other
tobacco NN Other
plus CC None
group NN Educational
support NN Educational
versus NN None
group NN Other
support NN Other
only RB Educational
. . None
Smokeless NNP Other
tobacco NN Other
group NN Educational
support NN Educational
visits NNS Educational
provided VBN Educational
by IN Educational
nurses NNS Educational
. . None
control NN Control
group NN Control
group NN Other
support NN Other
only RB Educational
. . None
Smokeless NNP Other
tobacco NN Other
-DOCSTART- -X- N

colon NN Educational
cancer NN Educational
screening VBG Educational
usual JJ Educational
care NN Educational
; : None
( ( Educational
2 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
; : None
( ( Educational
3 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
, , None
mailed VBN Educational
education NN Educational
, , None
CRC NNP Educational
reminder NN Educational
magnet NN Educational
, , None
and CC None
fecal JJ Educational
immunochemical JJ Educational
test NN Educational
( ( Educational
FIT NNP Educational
) ) Educational
( ( Educational
mailed JJ Educational
education/FIT NN Educational
) ) Educational
; : None
or CC None
( ( Educational
4 CD Educational
) ) Educational
all PDT Educational
the DT Educational
preceding VBG Educational
plus CC Educational
a DT Educational
structured JJ Educational
telephone NN Educational
call NN Educational
to TO Educational
the DT Educational
patient NN Educational
from IN Educational
project JJ Educational
staff NN Educational
to TO Educational
provide VB Educational
education NN Educational
, , None
assess JJ Educational
interest NN Educational
in IN Educational
screening VBG Educational
, , Educational
explain VB Educational
the DT Educational
screening NN Educational
tests NNS Educational
, , Educational
and CC Educational
address JJ Educational
barriers NNS Educational
-DOCSTART- -X- N

Intravenous JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IVF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
rt-PA NN Pharmocological
( ( Pharmocological
alteplase NN Pharmocological
) ) Pharmocological
Intra-arterial JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IAF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
pro-urokinase NN Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
urokinase JJ Pharmocological
IVF NNP Pharmocological
-DOCSTART- -X- N

methyldopa NN Pharmocological
labetalol NN Pharmocological
methyldopa NN Pharmocological
and CC None
labetalol NN Pharmocological
. . None
methyldopa NN Pharmocological
labetalol NN Pharmocological
. . Pharmocological
methyldopa NN Pharmocological
labetalol NN Pharmocological
. . Pharmocological
labetalol NN Pharmocological
. . Pharmocological
labetalol NN Pharmocological
methyldopa NN Pharmocological
-DOCSTART- -X- N

cuff NN Other
pressure NN Other
release NN Other
valve NN Other
. . None
release NN Other
valve NN Other
( ( None
with IN Other
and CC None
without IN Physical
CPRV NNP Other
) ) None
-DOCSTART- -X- N

acute NN Physical
exercise NN Physical
acute NN Physical
aerobic JJ Physical
exercise NN Physical
moderate JJ Physical
intensity NN Physical
aerobic JJ Physical
exercise NN Physical
for IN Physical
30 CD Physical
min NN Physical
running/exercise-related JJ Other
video NN Other
. . Other
of IN None
exercise NN Physical
-DOCSTART- -X- N

Hyperbaric NNP Pharmocological
oxygen NN Pharmocological
Hyperbaric NNP Pharmocological
oxygen NN Pharmocological
( ( Pharmocological
HBO NNP Pharmocological
) ) Pharmocological
HBO NNP Pharmocological
LPS NNP Pharmocological
injection NN Pharmocological
, , None
( ( None
ii NN None
) ) None
normal JJ Control
saline NN Control
( ( Control
N/S NNP Control
) ) Control
injection NN Control
, , None
( ( None
iii NN None
) ) None
hemin NN Pharmocological
( ( Pharmocological
a DT Pharmocological
HO-1 NNP Pharmocological
inducer NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
LPS NNP Pharmocological
, , None
( ( None
iv NN None
) ) None
hemin NN Pharmocological
alone RB None
, , None
( ( None
v NN None
) ) None
tin NN Pharmocological
protoporphyrin NN Pharmocological
( ( Pharmocological
SnPP NNP Pharmocological
; : Pharmocological
a DT Pharmocological
HO-1 NNP Pharmocological
inhibitor NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
LPS NNP Pharmocological
, , None
and CC None
( ( None
vi NN None
) ) None
SnPP NNP Pharmocological
alone RB None
. . None
high-dose JJ Pharmocological
pentobarbital JJ Pharmocological
injection NN Pharmocological
. . Pharmocological
HBO NNP Pharmocological
HBO NNP Pharmocological
HBO NNP Pharmocological
-DOCSTART- -X- N

ranolazine NN Pharmocological
concurrent JJ Pharmocological
antidiabetic JJ Pharmocological
therapy NN Pharmocological
Ranolazine NNP Pharmocological
glycemic NN None
and CC None
antidiabetes VBZ Pharmocological
drug NN Pharmocological
usage NN None
data NNS None
ranolazine NN Pharmocological
ranolazine NN Pharmocological
placebo NN Control
ranolazine NN Pharmocological
Ranolazine NNP Pharmocological
-DOCSTART- -X- N

new JJ Other
softcyte NN Other
a DT None
conventional JJ Other
endocyte NN Other
. . None
endocyte NN Other
softcyte NN Other
endocyte NN Other
. . Other
softcyte NN Other
endocyte NN Other
-DOCSTART- -X- N

imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
curettage VB Surgical
electrodesiccation NN Physical
Curettage NNP Surgical
and CC None
electrodesiccation NN Physical
( ( None
C NNP Physical
& CC Physical
D NNP Physical
) ) None
imiquimod NN Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Physical
& CC Physical
D NNP Physical
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
or CC None
vehicle NN Pharmocological
cream NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
. . None
imiquimod JJ Pharmocological
vehicle NN Control
imiquimod NN Pharmocological
Imiquimod NNP Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Surgical
& CC Surgical
D NNP Surgical
imiquimod JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Long RB Surgical
pediatric JJ Surgical
colonoscope NN Surgical
intermediate JJ Surgical
length NN Surgical
adult NN Surgical
colonoscope NN Surgical
long JJ Surgical
pediatric JJ Surgical
colonoscope NN Surgical
intermediate JJ Surgical
length NN Surgical
adult NN Surgical
colonoscope NN Surgical
colonoscopic NN Physical
examinations NNS Physical
colonoscopy NN Surgical
with IN Surgical
either DT Surgical
intermediate JJ Surgical
length NN Surgical
adult NN Surgical
colonoscope NN Surgical
( ( Surgical
CF-240I NNP Surgical
) ) Surgical
or CC None
long JJ Surgical
pediatric JJ Surgical
colonoscope NN Surgical
( ( Surgical
PCF-240L NNP Surgical
) ) Surgical
. . None
CF-240I NNP Surgical
PCF NNP Surgical
240L CD Surgical
intermediate JJ Surgical
length NN Surgical
adult NN Surgical
colonoscope NN Surgical
-DOCSTART- -X- N

omeprazole NN Pharmocological
. . Pharmocological
omeprazole NN Pharmocological
omeprazole JJ Pharmocological
omeprazole JJ Pharmocological
omeprazole JJ Pharmocological
Omeprazole NNP Pharmocological
omeprazole JJ Pharmocological
-DOCSTART- -X- N

hyaluronic JJ Pharmocological
acid NN Pharmocological
exercise VB Physical
therapy NN Physical
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
exercise NN Physical
therapy NN Physical
three CD Pharmocological
intra-articular JJ Pharmocological
HA NNP Pharmocological
injections NNS Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
-DOCSTART- -X- N

lorazepam NN Pharmocological
, , None
buspirone NN Pharmocological
, , None
and CC None
secobarbital NN Pharmocological
lorazepam NN Pharmocological
buspirone NN Pharmocological
secobarbital JJ Pharmocological
and CC None
placebo NN Control
buspirone RB Pharmocological
20 CD None
lorazepam JJ Pharmocological
, , None
secobarbital JJ Pharmocological
, , None
or CC None
buspirone RB Pharmocological
10 CD None
mg NN None
placebo VB Control
. . Control
Lorazepam NNP Pharmocological
buspirone NN Pharmocological
placebo NN Control
. . Control
lorazepam JJ Pharmocological
Buspirone CD Pharmocological
placebo NN Pharmocological
. . Pharmocological
buspirone NN Pharmocological
buspirone NN Pharmocological
Lorazepam NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

temporary JJ Surgical
clamping NN Surgical
of IN Surgical
drains NNS Surgical
immediate JJ Surgical
drain NN Surgical
opening NN Surgical
( ( None
n JJ None
= NNP None
45 CD None
) ) None
or CC None
drains NNS Surgical
opened VBN Surgical
at IN Surgical
2 CD Surgical
h NN Surgical
clamping VBG Surgical
drains NNS Surgical
drains NNS Surgical
-DOCSTART- -X- N

Propofol NNP Pharmocological
submucosal JJ None
Propofol NNP Pharmocological
-DOCSTART- -X- N

Computer-navigated JJ Surgical
versus NN None
conventional JJ Surgical
total JJ Surgical
knee NN Surgical
arthroplasty IN Surgical
computer-navigated JJ Surgical
total JJ Surgical
knee NN Surgical
arthroplasty NN Surgical
whether IN None
computer-navigated JJ Surgical
total JJ Surgical
knee NN Surgical
arthroplasty NN Surgical
improves VBZ None
the DT None
computernavigated JJ Surgical
total JJ Surgical
knee NN Surgical
arthroplasty NN Surgical
group NN None
the DT None
conventional JJ Surgical
total JJ Surgical
knee NN Surgical
arthroplasty NN Surgical
group NN None
-DOCSTART- -X- N

home-visit JJ Educational
invitation NN Educational
in-home JJ Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
intervention NN Educational
control VB Control
zone NN Control
. . Control
visited VBN Educational
in IN Educational
their PRP$ Educational
homes NNS Educational
by IN Educational
one CD Educational
of IN Educational
the DT Educational
researchers NNS Educational
, , Educational
who WP Educational
provided VBD Educational
culturally-sensitive JJ Educational
health NN Educational
education NN Educational
that WDT Educational
emphasized VBD Educational
the DT Educational
need NN Educational
for IN Educational
screening VBG Educational
. . Educational
screening-coverage JJ Educational
interviews NNS Educational
home NN Educational
visit NN Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
-DOCSTART- -X- N

B-domain NNP Pharmocological
deleted VBD Pharmocological
recombinant JJ Pharmocological
factor NN Pharmocological
VIII NNP Pharmocological
preparations NNS Pharmocological
( ( None
one CD None
reconstituted VBN None
with IN None
5 CD None
mL NNS None
of IN None
sterile JJ None
water NN None
, , None
the DT None
other JJ None
reconstituted VBD None
with IN None
4 CD None
mL NNS None
sodium JJ None
chloride RB None
0.9 CD None
% NN None
USP NNP None
) ) None
full-length JJ Pharmocological
FVIII NNP Pharmocological
preparation NN Pharmocological
( ( Pharmocological
Hemofil NNP Pharmocological
M NNP Pharmocological
) ) Pharmocological
BDDrFVIII NNP Pharmocological
formulation NN Pharmocological
-DOCSTART- -X- N

Aminocaproic NNP Pharmocological
acid VBZ Pharmocological
prednisone NN Pharmocological
aminocaproic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
Amicar NNP Pharmocological
) ) Pharmocological
systemic JJ Pharmocological
prednisone NN Pharmocological
oral JJ None
dosage NN None
of IN None
50 CD None
mg/kg NN None
of IN None
aminocaproic JJ Pharmocological
acid NN Pharmocological
oral JJ None
dosage NN None
of IN None
40 CD None
mg NN None
of IN None
prednisone JJ Pharmocological
daily JJ None
Placebo NNP Control
-DOCSTART- -X- N

Autism-Spectrum JJ Other
Quotient-Japanese JJ Other
Japanese JJ Other
version NN Other
of IN Other
the DT Other
Autism NNP Other
Spectrum NNP Other
Quotient NNP Other
( ( Other
AQ NNP Other
) ) Other
, , Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
. . Other
AQ-J JJ Other
-DOCSTART- -X- N

potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
10 CD None
mmol NN None
of IN None
potassium NN Pharmocological
and CC None
10 CD None
mmol NN None
of IN None
calcium NN Pharmocological
mixed VBN None
in IN None
their PRP$ None
table JJ None
salt JJ None
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
supplement NN Pharmocological
of IN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
-DOCSTART- -X- N

Glibenclamide NNP Pharmocological
vs NN None
gliclazide NN Pharmocological
glibenclamide NN Pharmocological
or CC None
gliclazide NN Pharmocological
. . None
capsule NN None
A NNP None
( ( None
glibenclamide NN Pharmocological
) ) None
capsule NN None
B NNP None
( ( None
gliclazide NN Pharmocological
) ) None
. . None
gliclazide NN Pharmocological
glibenclamide NN Pharmocological
gliclazide NN Pharmocological
glibenclamide NN Pharmocological
-DOCSTART- -X- N

tamsulosin NN Pharmocological
placebo-controlled JJ Control
tamsulosin NN Pharmocological
tamsulosin JJ Pharmocological
placebo NN Control
tamsulosin NN Pharmocological
Tamsulosin NNP Pharmocological
-DOCSTART- -X- N

Hydrogen NNP Pharmocological
peroxide NN Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
: : None
hydrogen NN Pharmocological
peroxide NN Pharmocological
( ( Pharmocological
H2O2 NNP Pharmocological
) ) Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
control NN Control
H2O2 NNP Pharmocological
or CC None
the DT None
group NN Control
. . None
H2O2 NNP Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
-DOCSTART- -X- N

15 CD None
mg JJ None
oral JJ None
dose NN None
of IN None
BMS-181101 NNP Pharmocological
twice NN None
a DT None
day NN None
morning NN None
dose NN None
of IN None
BMS-181101 NNP Pharmocological
on IN None
day NN None
12 CD None
. . None
BMS-181101 NNP Pharmocological
BMS-181101 NNP Pharmocological
BMS-181101 NNP Pharmocological
-DOCSTART- -X- N

parent-implemented JJ Educational
imitation NN Educational
intervention NN Educational
Reciprocal JJ Educational
imitation NN Educational
training NN Educational
( ( Educational
RIT NNP Educational
) ) Educational
is VBZ None
a DT None
naturalistic JJ None
imitation NN None
intervention NN None
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
-DOCSTART- -X- N

MMX NNP None
( ( None
? . None
) ) None
mesalamine NN None
with IN None
mesalamine NN None
MMX NNP None
( ( None
? . None
) ) None
mesalamine NN Pharmocological
( ( None
Lialda NNP None
; : None
Shire NNP None
Pharmaceuticals NNP None
LLC NNP None
, , None
Wayne NNP None
, , None
PA NNP None
) ) None
, , None
once-daily JJ None
MMX NNP None
mesalamine NN None
compared VBN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
( ( None
Asacol NNP Pharmocological
; : None
Warner NNP None
Chilcott NNP None
, , None
Dublin NNP None
, , None
Ireland NNP None
) ) None
for IN None
once-daily JJ None
MMX NNP None
mesalamine NN None
2.4 CD None
with IN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
at IN None
a DT None
total JJ None
daily JJ None
dose NN None
of IN None
1.6 CD None
g/day NN None
in IN None
-DOCSTART- -X- N

-DOCSTART- -X- N

Allogeneic NNP Pharmocological
marrow NN Pharmocological
transplantation NN Pharmocological
total JJ Other
body NN Other
irradiation NN Other
cyclophosphamide JJ Pharmocological
total JJ Other
body NN Other
irradiation NN Other
and CC None
marrow NN Pharmocological
from IN Pharmocological
HLA-identical JJ Pharmocological
siblings NNS Pharmocological
. . None
Cyclosporine NNP Pharmocological
and CC None
methotrexate NN Pharmocological
irradiation NN Other
-DOCSTART- -X- N

Low-dose JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
low-dose JJ Pharmocological
aspirin NN Pharmocological
placebo-controlled JJ Control
aspirin NN Pharmocological
and CC None
beta NN Pharmocological
carotene NN Pharmocological
. . None
aspirin NN Pharmocological
and CC None
placebo NN Control
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Contingency NNP Educational
management NN Educational
Contingency NNP Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
CM NNP Educational
The DT None
combination NN None
of IN None
a DT None
standardized JJ None
lifestyle NN None
modification NN None
( ( None
LM NNP None
) ) None
program NN None
payment NN None
for IN None
group NN None
attendance NN None
( ( None
CM NNP None
( ( None
attendance NN None
) ) None
) ) None
, , None
ii NN None
) ) None
The DT None
combination NN None
of IN None
LM NNP None
and CC None
payment NN None
for IN None
weight JJ None
loss NN None
( ( None
CM NNP None
( ( None
weight NN None
) ) None
) ) None
, , None
and CC None
iii NN None
) ) None
waitlist NN None
control NN None
( ( None
CON NNP None
) ) None
. . None
LM NNP None
group NN None
and CC None
received VBD None
payment NN None
for IN None
behavioral JJ None
change NN None
( ( None
CM NNP None
( ( None
behavior NN None
) ) None
) ) None
. . None
CONCLUSION NNP None
LM NNP None
supplemented VBD None
with IN None
CM NNP None
may MD None
-DOCSTART- -X- N

Clofarabine NNP Pharmocological
? . Pharmocological
fludarabine NN Pharmocological
busulfan NN None
of IN None
i.v NN None
. . None
busulfan NN None
( ( None
Bu NNP None
) ) None
and CC None
fludarabine NN Pharmocological
( ( None
Flu NNP None
) ) None
supplant VB None
Flu NNP None
with IN None
clofarabine NN Pharmocological
( ( None
Clo NNP None
) ) None
, , None
I-Clo NN None
: : None
Flu CD None
IV-single-agent NNP None
Clo NNP None
? . None
Flu NNP None
with IN None
i.v NN None
. . None
Bu NNP None
as IN None
-DOCSTART- -X- N

glycerol NN Pharmocological
glycerol NN Pharmocological
glucose NN Control
glycerol NN Pharmocological
glucose NN Control
. . None
glycerol NN Pharmocological
. . None
glycerol NN Pharmocological
glycerol NN Pharmocological
glycerol NN Pharmocological
glycerol NN Pharmocological
. . None
glycerol NN Pharmocological
glucose JJ Control
glycerol NN Pharmocological
-DOCSTART- -X- N

heparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
UFH NNP Pharmocological
administration NN None
of IN None
two CD None
LMWHs NNP Pharmocological
. . None
UFH NNP Pharmocological
dalteparin NN Pharmocological
, , None
200 CD None
U/kg NNP None
once RB None
daily RB None
, , None
and CC None
enoxaparin RB Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
LMWHs NNP Pharmocological
UFH NNP Pharmocological
-DOCSTART- -X- N

Dader NNP Educational
Method NNP Educational
pharmacist JJ Educational
intervention NN Educational
community NN Educational
pharmacist NN Educational
interventions NNS Educational
Dader NNP Educational
Method NNP Educational
for IN Educational
pharmaceutical JJ Educational
care NN Educational
intervention NN Educational
group NN Educational
that WDT Educational
received VBD Educational
pharmaceutical JJ Educational
care NN Educational
, , Educational
which WDT Educational
was VBD Educational
provided VBN Educational
by IN Educational
specially RB Educational
trained JJ Educational
pharmacists NNS Educational
working VBG Educational
in IN Educational
collaboration NN Educational
with IN Educational
physicians NNS Educational
control NN Educational
group NN Educational
that WDT Educational
received VBD Educational
usual JJ Educational
care NN Educational
( ( Educational
routine JJ Educational
dispensing VBG Educational
counseling NN Educational
) ) Educational
and CC Educational
verbal JJ Educational
and CC Educational
written VBN Educational
counseling VBG Educational
regarding VBG Educational
CVD NNP Educational
prevention NN Educational
. . None
intervention NN None
control NN None
) ) None
usual JJ None
care NN None
plus CC None
written VBN None
education NN None
, , None
pharmaceutical JJ None
care NN None
focused VBN None
on IN None
patient JJ None
evaluation NN None
and CC None
follow-up NN None
in IN None
collaboration NN None
with IN None
physicians NNS None
-DOCSTART- -X- N

titanoreine NN Pharmocological
titanoreine NN Pharmocological
titanoreine VB Pharmocological
control VB Control
group NN Control
without IN Control
titanoreine NN Control
titanoreine NN Pharmocological
titanoreine NN Pharmocological
Titanoreine NNP Pharmocological
-DOCSTART- -X- N

nuclear JJ Other
magnetic JJ Other
resonance NN Other
imaging NN Other
. . Other
nuclear JJ Other
magnetic JJ Other
resonance NN Other
( ( Other
NMR NNP Other
) ) Other
imaging NN Other
NMR NNP Other
images NNS Other
-DOCSTART- -X- N

unexpected JJ Physical
forward NN Physical
perturbations NNS Physical
( ( Physical
FP NNP Physical
) ) Physical
FP NNP Physical
FP NNP Physical
. . Physical
-DOCSTART- -X- N

therapeutic JJ Physical
targets NNS Physical
-DOCSTART- -X- N

minimally RB Surgical
invasive JJ Surgical
or CC None
conventional JJ Surgical
esophageal JJ Surgical
resection NN Surgical
conventional JJ Surgical
open JJ Surgical
esophagectomy NN Surgical
thoracotomy NN Surgical
and CC None
laparotomy NN Surgical
minimally RB Surgical
invasive JJ Surgical
esophagectomy NN Surgical
[ NNP None
minimally RB None
invasive JJ None
procedure NN None
( ( None
MIE NNP None
) ) None
] NN None
by IN None
thoracoscopy NN Surgical
and CC None
laparoscopy NN Surgical
. . None
MIE NNP Surgical
-DOCSTART- -X- N

Placebo-Controlled NNP Control
Selective NNP None
A1 NNP None
Adenosine NNP None
Receptor NNP None
Antagonist NNP None
Rolofylline NNP Pharmocological
rolofylline NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

maximal JJ Pharmocological
oxygenation NN Pharmocological
oxygenation NN Pharmocological
( ( Pharmocological
SaO2 NNP Pharmocological
) ) Pharmocological
positioned VBN None
on IN None
their PRP$ None
sides NNS None
with IN None
the DT None
unaffected JJ None
lung NN None
down RP None
, , None
on IN None
their PRP$ None
sides NNS None
with IN None
the DT None
affected JJ None
lung NN None
down RB None
, , None
and CC None
also RB None
in IN None
semi-Fowler NN None
's POS None
position NN None
. . None
-DOCSTART- -X- N

5-aminolevulinic JJ Pharmocological
acid NN Pharmocological
5-aminolevulinic JJ Pharmocological
acid NN Pharmocological
fluorescence NN None
diagnosis NN None
. . None
Transurethral JJ Surgical
resection NN Surgical
white JJ None
light JJ None
cystoscopy NN None
urine JJ None
cytology NN None
. . None
-DOCSTART- -X- N

fluconazole NN Pharmocological
miconazole NN Pharmocological
. . Pharmocological
Fluconazole NNP Pharmocological
Single-dose JJ None
fluconazole NN Pharmocological
( ( None
150 CD None
mg NN None
) ) None
administered VBD None
orally RB None
in IN None
capsule NN None
form NN None
was VBD None
compared VBN None
with IN None
three-day JJ None
local JJ None
treatment NN None
with IN None
miconazole JJ Pharmocological
pessaries NNS None
in IN None
the DT None
miconazole NN Pharmocological
fluconazole JJ Pharmocological
fluconazole NN Pharmocological
-DOCSTART- -X- N

tonabersat NN Pharmocological
Tonabersat NNP Pharmocological
40 CD None
mg NN None
tonabersat NN Pharmocological
once IN None
daily JJ None
was VBD None
compared VBN None
with IN None
matched JJ None
placebo NN Control
placebo NN Control
placebo NN Control
tonabersat NN Pharmocological
Tonabersat NNP Pharmocological
-DOCSTART- -X- N

acupressure NN None
Premedication NNP None
with IN None
sedatives NNS None
acupressure NN Physical
acupressure NN Physical
at IN Physical
the DT Physical
extra JJ Physical
1 CD Physical
point NN Physical
sham NN None
group NN None
acupressure NN Control
at IN Control
a DT Control
sham JJ Control
point NN Control
. . None
electrocardiogram NN None
Acupressure NN Physical
acupressure NN Physical
Acupressure NN Physical
Acupressure NN Physical
acupressure NN Physical
acupressure NN Physical
-DOCSTART- -X- N

Niacin NNP Pharmocological
wax-matrix JJ None
sustained-release JJ None
niacin NN Pharmocological
niacin NN Pharmocological
( ( Pharmocological
Enduracin NNP Pharmocological
) ) Pharmocological
niacin JJ Pharmocological
placebo- JJ Control
and CC None
diet-treated JJ Control
controls NNS Control
niacin NN Pharmocological
-DOCSTART- -X- N

Pegfilgrastim NN Pharmocological
pegfilgrastim+/-chemotherapy NN Pharmocological
pegfilgrastim NN Pharmocological
filgrastim NNS Pharmocological
pegfilgrastim NN Pharmocological
filgrastim JJR Pharmocological
pegfilgrastim NN Pharmocological
filgrastim NN Pharmocological
; : Pharmocological
carboplatin/paclitaxel NNS Pharmocological
pegfilgrastim JJ Pharmocological
filgrastim NN Pharmocological
pegfilgrastim NN Pharmocological
filgrastim NN Pharmocological
pegfilgrastim NN Pharmocological
pegfilgrastim NN Pharmocological
filgrastim NN Pharmocological
-DOCSTART- -X- N

physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
lifestyle JJ Educational
intervention NN Educational
control NN Control
daily JJ Educational
activity NN Educational
monitoring NN Educational
and CC Educational
distance NN Educational
counselling NN Educational
. . Educational
daily JJ None
physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
-DOCSTART- -X- N

Pedantic JJ Psychological
speaking NN Psychological
pedantic JJ Psychological
speech NN Psychological
pedantic JJ Psychological
speech NN Psychological
-DOCSTART- -X- N

placebo NN Control
finasteride NN Pharmocological
finasteride NN Pharmocological
finasteride NN Pharmocological
5 CD Pharmocological
mg. NNS Pharmocological
finasteride JJ Pharmocological
daily RB Pharmocological
or CC None
placebo VB Control
finasteride NN Pharmocological
placebo NN Control
. . None
finasteride NN Pharmocological
finasteride NN Pharmocological
-DOCSTART- -X- N

tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
everolimus NN Pharmocological
tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
( ( Pharmocological
TKI NNP Pharmocological
) ) Pharmocological
sunitinib NN Pharmocological
or CC None
sorafenib NN Pharmocological
. . None
TKI NNP Pharmocological
TKI NNP Pharmocological
everolimus NN Pharmocological
: : None
sunitinib NN Pharmocological
sorafenib NN Pharmocological
dovitinib NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI NNP Pharmocological
everolimus NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI JJ Pharmocological
sequence NN Pharmocological
-DOCSTART- -X- N

fluke NNS Pharmocological
and CC Pharmocological
worm VB Pharmocological
combination NN Pharmocological
products NNS Pharmocological
ivermectin NN Pharmocological
+ NNP None
clorsulon NN Pharmocological
injection NN Pharmocological
, , None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
injection NN Pharmocological
, , None
or CC None
levamisole JJ Pharmocological
+ JJ None
triclabendazole JJ Pharmocological
oral JJ None
drench NN None
. . None
ivermectin JJ Pharmocological
+ NN None
clorsulon NN Pharmocological
( ( None
single JJ None
injection NN None
) ) None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
levamisole JJ Pharmocological
+ JJ None
triclabendazole NN Pharmocological
-DOCSTART- -X- N

clopidogrel NN Pharmocological
clopidogrel NN Pharmocological
75 CD None
mg/day JJ None
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
89 CD None
) ) None
or CC None
placebo JJ Control
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
92 CD None
) ) None
for IN None
9 CD None
weeks NNS None
clopidogrel NN Pharmocological
plus CC None
aspirin JJ Pharmocological
placebo NN Control
plus CC None
aspirin NN Pharmocological
clopidogrel NN Pharmocological
-DOCSTART- -X- N

night NN Physical
splint NN Physical
to TO None
eccentric VB Physical
exercises NNS Physical
use NN None
of IN None
a DT None
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
with IN Physical
a DT Physical
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
only RB Physical
heavy-load NN Physical
eccentric JJ Physical
training NN Physical
programme NN Physical
. . Physical
night NN Physical
splint NN Physical
in IN None
addition NN None
to TO None
eccentric JJ Physical
exercises NNS Physical
. . None
night NN Physical
splint NN Physical
night NN Physical
splint NN Physical
-DOCSTART- -X- N

Levitan NNP Physical
FPS NNP Physical
Scope? NNP Physical
the DT None
Levitan NNP Physical
FPS NNP Physical
( ( Physical
first JJ Physical
pass NN Physical
success NN Physical
) ) Physical
Scope? NNP Physical
( ( Physical
LFS NNP Physical
) ) Physical
is VBZ None
initial JJ None
laryngoscopy NN None
was VBD None
Macintosh NNP Physical
or CC None
the DT None
LFS NNP Physical
in IN None
conjunction NN None
with IN None
the DT None
Macintosh NNP None
. . None
Following VBG None
grading NN None
, , None
a DT None
second JJ None
laryngoscopy NN None
was VBD None
Macintosh NNP Physical
laryngoscope NN None
does VBZ None
-DOCSTART- -X- N

COMET NNP None
carvedilol NN Pharmocological
antagonist NN Pharmocological
metoprolol NN Pharmocological
, , None
a DT None
beta-1-selective JJ Pharmocological
agent NN Pharmocological
carvedilol NN Pharmocological
COMET NNP None
-DOCSTART- -X- N

placebo-controlled JJ Control
pravastatin NN Pharmocological
-DOCSTART- -X- N

euglycemic JJ Surgical
insulin NN Surgical
clamp NN Surgical
and CC Surgical
[ JJ Surgical
1-14C JJ Surgical
] NNP Surgical
leucine NN Surgical
turnover NN Surgical
techniques NNS Surgical
. . Surgical
-DOCSTART- -X- N

pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
pyridostigmine NN Pharmocological
on IN None
the DT None
night NN None
before IN None
surgery NN None
morning NN None
dose NN None
of IN None
the DT None
drug NN None
on IN None
the DT None
day NN None
of IN None
surgery NN None
. . None
Neostigmine NNP Pharmocological
Vecuronium NNP Pharmocological
trans-sternal JJ Surgical
thymectomy NN Surgical
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
vecuronium NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

naltrexone NN Pharmocological
hydrochloride NN Pharmocological
placebo-controlled JJ Control
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
. . Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
Naltrexone CD Pharmocological
naltrexone RB Pharmocological
-DOCSTART- -X- N

Information NNP Educational
source NN Educational
videotape NN Educational
-DOCSTART- -X- N

cooperation NN Other
radioiodine JJ Pharmocological
treatment NN None
radioiodine NN Pharmocological
substitution NN None
therapy NN None
radioiodine NN Pharmocological
radioiodine NN Pharmocological
radiation NN Physical
therapy NN Physical
cooperation NN Other
-DOCSTART- -X- N

Extracorporeal NNP Physical
shock NN Physical
wave NN Physical
therapy NN Physical
( ( Physical
ESWT NNP Physical
) ) Physical
extracorporeal NN Physical
shock NN Physical
wave VBP Physical
therapy NN Physical
Heel NNP Physical
cups NNS Physical
ESWT NNP Physical
( ( None
3000 CD None
shock NN None
waves/session NN None
of IN None
0.2 CD None
mJ/mm2 NN None
) ) None
at IN None
weekly JJ None
intervals NNS None
. . None
nonsurgical JJ None
treatment NN None
( ( None
iontophoresis NN Pharmocological
with IN Pharmocological
diclofenac NN Pharmocological
and CC None
an DT None
oral JJ None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
) ) None
-DOCSTART- -X- N

Fine NNP Surgical
needle JJ Surgical
aspiration NN Surgical
coupled VBN Surgical
with IN Surgical
real-time JJ Physical
PCR NNP Physical
: : None
methodology NN Physical
fine JJ Physical
needle JJ Physical
aspiration NN Physical
technique NN Physical
Multiplex NNP Physical
tandem VBD Physical
RT-PCR NNP Physical
painless JJ Physical
methodology NN Physical
-DOCSTART- -X- N

Midazolam NNP Pharmocological
vs NN None
ondansetron NN Pharmocological
midazolam NN Pharmocological
ondansetron NN Pharmocological
Midazolam NNP Pharmocological
2 CD Pharmocological
mg NN Pharmocological
or CC None
ondansetron $ Pharmocological
4 CD Pharmocological
mg NN Pharmocological
ondansetron NN Pharmocological
midazolam VB Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
analog NN Pharmocological
( ( Pharmocological
Diphereline NNP Pharmocological
) ) Pharmocological
Cabergoline NNP Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
) ) Pharmocological
cabergoline NN Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
, , Pharmocological
a DT Pharmocological
dopamine JJ Pharmocological
agonist NN Pharmocological
) ) Pharmocological
Diphereline NNP Pharmocological
( ( Pharmocological
a DT Pharmocological
gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
) ) Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
Cabergoline NNP Pharmocological
gonadotropin NN Pharmocological
releasing VBG Pharmocological
hormone JJ Pharmocological
agonist NN Pharmocological
dopamine NN Pharmocological
agonists NNS Pharmocological
-DOCSTART- -X- N

medical JJ Pharmocological
or CC None
surgical JJ Surgical
treatment NN None
bypass NN Surgical
surgery NN Surgical
surgery VB Surgical
-DOCSTART- -X- N

acupuncture NN Physical
and CC None
moxibustion NN Pharmocological
therapies NNS None
acupuncture NN Physical
and CC None
moxibustion NN Pharmocological
warming VBG None
needle JJ None
moxibustion NN Pharmocological
acupuncture NN Physical
plus CC None
auricular JJ Physical
point NN Physical
sticking NN Physical
routine JJ Physical
acupuncture NN Physical
. . Physical
warming VBG None
needle JJ None
moxibustion NN Pharmocological
-DOCSTART- -X- N

patient-controlled JJ Pharmocological
and CC None
nurse-administered JJ Pharmocological
analgesia NN Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
patient-controlled JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
fentanyl NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
nurses NNS Pharmocological
on IN Pharmocological
request NN Pharmocological
. . Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
patient NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
nurses NNS Pharmocological
-DOCSTART- -X- N

Paricalcitol NNP Pharmocological
capsule NN Pharmocological
paricalcitol NN Pharmocological
paricalcitol NNS Pharmocological
placebo NN Control
. . None
Paricalcitol NNP Pharmocological
-DOCSTART- -X- N

Hip NNP Physical
protectors NNS Physical
external JJ Physical
hip NN Physical
protectors NNS Physical
external JJ Physical
hip NN Physical
protectors NNS Physical
and CC None
encouragement NN Physical
to TO Physical
use VB Physical
the DT Physical
protectors NNS Physical
by IN Physical
an DT Physical
adherence NN Physical
nurse NN Physical
. . None
hip NN Physical
protectors NNS Physical
Hip NNP Physical
protector NN Physical
Hip NNP Physical
protectors NNS Physical
hip NN Physical
protectors NNS Physical
-DOCSTART- -X- N

dexketoprofen NN Pharmocological
dexketoprofen NNS Pharmocological
trometamol VBP Pharmocological
ilioinguinal JJ Pharmocological
iliohypogastric JJ Pharmocological
block NN Pharmocological
saline NN Pharmocological
DB NNP Pharmocological
levobupivacaine NN Pharmocological
) ) None
dexketoprofen RB Pharmocological
. . None
morphine JJ Pharmocological
analgesia NN Pharmocological
IV NNP None
dexketoprofen NN None
increases NNS None
-DOCSTART- -X- N

control NN None
, , None
treated VBN None
with IN None
full-mouth JJ Physical
scaling NN Physical
and CC None
root NN Physical
planing NN Physical
( ( Physical
SRP NNP Physical
) ) Physical
; : None
treated VBN None
with IN None
SRP NNP Surgical
and CC None
400 CD None
mg NNS None
systemically RB None
administered VBN None
metronidazole NN Pharmocological
( ( None
MET NNP None
) ) None
treated VBN None
with IN None
SRP NNP Physical
and CC None
professional JJ Physical
supragingival NN Physical
plaque NN Physical
removal NN Physical
( ( Physical
PP NNP Physical
) ) Physical
SRP NNP Surgical
and CC None
MET NNP Pharmocological
plus CC None
PP NNP None
. . None
Periodontal NNP Physical
treatment NN Physical
-DOCSTART- -X- N

educational JJ Other
baby NN Other
books NNS Other
an DT None
educational JJ Other
book NN Other
group NN Other
, , None
a DT None
noneducational JJ Other
book NN Other
group NN Other
, , None
or CC None
a DT None
no-book JJ Control
group NN Control
. . None
-DOCSTART- -X- N

aliskiren NN Pharmocological
placebo VB Control
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( None
perindopril NN Pharmocological
) ) None
receive VB None
aliskiren NNS None
( ( None
150 CD None
, , None
aliskiren RB None
( ( None
300 CD None
, , None
perindopril NN None
( ( None
5 CD None
, , None
perindopril NN None
( ( None
10 CD None
placebo NN None
. . None
RESULTS NNP None
Aliskiren NNP None
and CC None
perindopril NN None
aliskiren NNS None
( ( None
150 CD None
) ) None
with IN None
aliskiren NN None
( ( None
300 CD None
mg NN None
with IN None
perindopril NN None
( ( None
5 CD None
mg NN None
) ) None
and CC None
with IN None
perindopril NN None
( ( None
10 CD None
mg NN None
) ) None
, , None
compared VBN None
placebo VB None
aliskiren NNS None
and CC None
perindopril NN None
. . None
CONCLUSIONS NNP None
Aliskiren NNP None
perindopril NN None
, , None
for IN None
equivalent JJ None
The DT None
renin JJ None
inhibitor NN None
-DOCSTART- -X- N

decaffeinated JJ Pharmocological
coffee NN Pharmocological
chlorogenic JJ Pharmocological
trigonelline NN Pharmocological
Coffee NNP Pharmocological
decaffeinated JJ Pharmocological
coffee NN Pharmocological
decaffeinated VBD Pharmocological
coffee NN Pharmocological
chlorogenic JJ Pharmocological
acid NN Pharmocological
trigonelline NN Pharmocological
, , None
and CC None
placebo NN Control
mannitol NN Pharmocological
) ) Pharmocological
placebo NN Control
. . Control
-DOCSTART- -X- N

family NN Educational
practice-based JJ Educational
lifestyle JJ Educational
intervention NN Educational
program NN Educational
multi-component JJ Educational
lifestyle JJ Educational
intervention NN Educational
standard NN Educational
of IN Educational
care NN Educational
lifestyle JJ Educational
intervention NN Educational
behaviourally-based JJ Educational
, , Educational
matched VBD Educational
prescriptive JJ Educational
physical JJ Educational
activity NN Educational
and CC Educational
diet JJ Educational
change NN Educational
program NN Educational
. . None
-DOCSTART- -X- N

Troponin NNP Other
T NNP Other
( ( Other
TnT NNP Other
) ) Other
measurements NNS Other
electrocardiographic JJ Other
( ( Other
ECG NNP Other
) ) Other
recordings NNS Other
-DOCSTART- -X- N

neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
laser NN Surgical
treatment NN Surgical
cold JJ Surgical
knife NN Surgical
endoscopic NN Surgical
incision NN Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
treatment NN Surgical
with IN Surgical
neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
( ( Surgical
Nd NNP Surgical
: : Surgical
YAG NN Surgical
) ) Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
of IN Surgical
urethral JJ Surgical
strictures NNS Surgical
( ( Surgical
VLASU NNP Surgical
) ) Surgical
with IN Surgical
Nd NNP Surgical
: : Surgical
YAGlaser NN Surgical
correction NN None
of IN None
urethral JJ None
strictures NNS None
using VBG None
Sachse NNP Surgical
's POS Surgical
optical JJ Surgical
urethrotomy NN Surgical
. . None
optical JJ Surgical
urethrotomy NN Surgical
VLASU NNP Surgical
VLASU NNP Surgical
VLASU NNP Surgical
-DOCSTART- -X- N

rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
placebo NN Control
or CC None
rosuvastatin VB Pharmocological
20 CD None
mg NN None
Rosuvastatin NNP Pharmocological
Rosuvastatin NNPS Pharmocological
rosuvastatin VBP Pharmocological
rosuvastatin NN Pharmocological
-DOCSTART- -X- N

homocysteine NN None
lipid JJ None
levels NNS None
-DOCSTART- -X- N

Clonidine NN Pharmocological
clonidine NN Pharmocological
saline NN Control
2-micrograms/kg JJ None
bolus NN None
of IN None
clonidine NN Pharmocological
-DOCSTART- -X- N

Iron NNP Pharmocological
Iron NNP Pharmocological
Dietary NNP Pharmocological
iron NN Pharmocological
iron NN Pharmocological
iron NN Pharmocological
-DOCSTART- -X- N

RCT NNP None
of IN None
yoga NN Physical
, , None
exercise NN Physical
, , None
and CC None
omega-3 JJ Pharmocological
supplements NNS Pharmocological
. . None
3 CD None
nonhormonal JJ None
therapies NNS None
to TO None
yoga VB Physical
exercise NN None
or CC None
usual JJ Control
activity NN Control
of IN None
omega-3 JJ Pharmocological
177 CD None
) ) None
or CC None
placebo NN Control
1 CD None
) ) None
weekly JJ None
90-minute CD None
yoga NN None
classes NNS None
with IN None
daily JJ None
at-home JJ None
practice NN None
, , None
( ( None
2 CD None
) ) None
individualized VBN None
facility-based JJ None
aerobic JJ None
exercise NN None
training NN None
3 CD None
times/week NN None
, , None
omega-3 JJ Pharmocological
supplement NN Pharmocological
, , None
For IN None
yoga NN None
underwent VBP None
exercise NN Physical
and CC None
omega-3 JJ Pharmocological
therapy NN Pharmocological
yoga NN None
-DOCSTART- -X- N

rituximab NN Pharmocological
rituximab NN Pharmocological
( ( Pharmocological
RTX NNP Pharmocological
) ) Pharmocological
placebo VB Control
( ( None
PBO NNP None
) ) None
+ NN Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
; : Pharmocological
PBO-randomized NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
RTX NNP Pharmocological
+ NNP Pharmocological
MTX NNP Pharmocological
( ( Pharmocological
RTX-randomized NNP Pharmocological
) ) Pharmocological
. . None
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX-randomized JJ Pharmocological
RTX NNP Pharmocological
RTX-randomized NNP Pharmocological
both DT None
PBO-randomized NNP None
( ( None
and CC None
RTX-randomized NNP None
( ( None
PBO-randomized NNP None
versus NN None
RTX-randomized JJ None
patients NNS None
CONCLUSION NNP None
RTX NNP None
re-treatment NN None
over IN None
initiating VBG None
RTX NNP None
treatment NN None
may MD None
